epic3: national evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England

H P Loveday, J A Wilson, R J Pratt, M Golsorkhi, A Tingle, A Bak, J Browne, J Prieto, M Wilcox, UK Department of Health, H P Loveday, J A Wilson, R J Pratt, M Golsorkhi, A Tingle, A Bak, J Browne, J Prieto, M Wilcox, UK Department of Health

Abstract

National evidence-based guidelines for preventing healthcare-associated infections (HCAI) in National Health Service (NHS) hospitals in England were originally commissioned by the Department of Health and developed during 1998-2000 by a nurse-led multi-professional team of researchers and specialist clinicians. Following extensive consultation, they were first published in January 2001(1) and updated in 2007.(2) A cardinal feature of evidence-based guidelines is that they are subject to timely review in order that new research evidence and technological advances can be identified, appraised and, if shown to be effective for the prevention of HCAI, incorporated into amended guidelines. Periodically updating the evidence base and guideline recommendations is essential in order to maintain their validity and authority. The Department of Health commissioned a review of new evidence and we have updated the evidence base for making infection prevention and control recommendations. A critical assessment of the updated evidence indicated that the epic2 guidelines published in 2007 remain robust, relevant and appropriate, but some guideline recommendations required adjustments to enhance clarity and a number of new recommendations were required. These have been clearly identified in the text. In addition, the synopses of evidence underpinning the guideline recommendations have been updated. These guidelines (epic3) provide comprehensive recommendations for preventing HCAI in hospital and other acute care settings based on the best currently available evidence. National evidence-based guidelines are broad principles of best practice that need to be integrated into local practice guidelines and audited to reduce variation in practice and maintain patient safety. Clinically effective infection prevention and control practice is an essential feature of patient protection. By incorporating these guidelines into routine daily clinical practice, patient safety can be enhanced and the risk of patients acquiring an infection during episodes of health care in NHS hospitals in England can be minimised.

Copyright © 2014 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.

Figures

https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7114876/bin/fx1_lrg.jpg

References

    1. Pratt RJ, Pellowe C, Loveday HP, Department of Health (England) The epic project: developing national evidence-based guidelines for preventing healthcare associated infections. Phase I: Guidelines for preventing hospital-acquired infections. J Hosp Infect. 2001;47(Suppl. l):S3–S82.
    1. Pratt RJ, Pellowe CM, Wilson JA. epic2: National evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England. J Hosp Infect. 2007;65(Suppl. 1):S1–S59.
    1. AGREE II Instrument Appraisal of guidelines for research and evaluation Il. 2009. Accessed October 5, 2012.
    1. Scottish Intercollegiate Guidelines Network . SIGN 50: a guideline developer's handbook. Revised edition. Heathcare Improvement Scotland; Edinburgh: 2011. Accessed July 25, 2013.
    1. Cochrane Effective Practice and Organisation of Care Review Group . EPOC resources. The Cochrane Collaboration; 2013. Accessed 6 August, 2013.
    1. Department of Health . The Health and Social Care Act 2008: code of practice for the NHS on the prevention and control of healthcare associated infections and related guidance. Department of Health; London: 2009.
    1. Department of Health . Decontamination of re-usable medical devices in the primary, secondary and tertiary care sectors (NHS and independent providers) Department of Health; London: 2007.
    1. Care Quality Commission . Guidance about compliance. Essential standards of quality and safety. Care Quality Commission; London: 2010. Accessed August 1, 2013.
    1. National Patient Safety Agency . The revised healthcare cleaning manual. NPSA; London: 2009. Accessed July 19, 2013.
    1. National Institute for Health and Care Excellence . Guidance 36. Prevention and control of healthcare-associated infections. Quality improvement guide. National Institute for Health and Care Excellence; London: 2011. Accessed July 25, 2013.
    1. Boyce JM, Havill NL, Otter JA, Adams NMT. Widespread environmental contamination associated with patients with diarrhea and methicillin-resistant Staphylococcus aureus colonization of the gastrointestinal tract. Infect Control Hosp Epidemiol. 2007;28:1142–1147.
    1. Dancer SJ. Importance of the environment in meticillin-resistant Staphylococcus aureus acquisition: the case for hospital cleaning. Lancet Infect Dis. 2008;8:101–113.
    1. Griffiths R, Fernandez R, Halcomb E. Reservoirs of MRSA in the acute hospital setting: a systematic review. Contemp Nurse. 2002;13:38–49.
    1. Barker J, Vipond IB, Bloomfield SF. Effects of cleaning and disinfection in reducing the spread of Norovirus contamination via environmental surfaces. J Hosp Infect. 2004;58:42–49.
    1. Denton M, Wilcox MH, Parnell P. Role of environmental cleaning in controlling an outbreak of Acinetobacter baumannii on a neurosurgical intensive care unit. J Hosp Infect. 2004;56:106–110.
    1. Wilcox MH, Fawley WN, Wigglesworth N, Parnell P, Verity P, Freeman J. Comparison of the effect of detergent versus hypochlorite cleaning on environmental contamination and incidence of Clostridium difficile infection. J Hosp Infect. 2003;54:109–114.
    1. Boyce JM, Potter-Bynoe G, Chenevert C, King T. Environmental contamination due to methicillin-resistant Staphylococcus aureus: possible infection control implications. Infect Control Hosp Epidemiol. 1997;18:622–627.
    1. Oie S, Hosokawa I, Kamiya A. Contamination of room door handles by methicillin-sensitive/methicillin-resistant Staphylococcus aureus. J Hosp Infect. 2002;51:140–143.
    1. Schultz M, Gill J, Zubairi S, Huber R, Gordin F. Bacterial contamination of computer keyboards in a teaching hospital. Infect Control Hosp Epidemiol. 2003;24:302–303.
    1. Brooks SE, Walczak MA, Hameed R, Coonan P. Chlorhexidine resistance in antibiotic-resistant bacteria isolated from the surfaces of dispensers of soap containing chlorhexidine. Infect Control Hosp Epidemiol. 2002;23:692–695.
    1. Nseir S, Blazejewski C, Lubret R, Wallet F, Courcol R, Durocher A. Risk of acquiring multidrug-resistant Gram-negative bacilli from prior room occupants in the intensive care unit. Clin Microbiol Infect. 2011;17:1201–1208.
    1. Huang SS, Datta R, Platt R. Risk of acquiring antibiotic-resistant bacteria from prior room occupants. Arch Intern Med. 2006;166:1945–1951.
    1. Shaughnessy MK, Micielli RL, DePestel DD. Evaluation of hospital room assignment and acquisition of Clostridium difficile infection. Infect Control Hosp Epidemiol. 2011;32:201–206.
    1. Rampling A, Wiseman S, Davis L. Evidence that hospital hygiene is important in the control of methicillin-resistant Staphylococcus aureus. J Hosp Infect. 2001;49:109–116.
    1. Wilson AP, Smyth D, Moore G. The impact of enhanced cleaning within the intensive care unit on contamination of the near-patient environment with hospital pathogens: a randomized crossover study in critical care units in two hospitals. Crit Care Med. 2011;39:651–658.
    1. Dettenkofer M, Wenzler S, Amthor S, Antes G, Motschall E, Daschner FD. Does disinfection of environmental surfaces influence nosocomial infection rates? A systematic review. Am J Infect Control. 2004;32:84–89.
    1. Otter JA, Puchowicz M, Ryan D. Feasibility of routinely using hydrogen peroxide vapor to decontaminate rooms in a busy United States hospital. Infect Control Hosp Epidemiol. 2009;30:574–577.
    1. Kundrapu S, Sunkesula V, Jury LA, Sitzlar BM, Donskey CJ. Daily disinfection of high-touch surfaces in isolation rooms to reduce contamination of healthcare workers' hands. Infect Control Hosp Epidemiol. 2012;33:1039–1042.
    1. Dancer S, White L, Lamb J, Girvan EK, Robertson C. Measuring the effect of enhanced cleaning in a UK hospital: a prospective cross-over study. BMC Med. 2009;7:28.
    1. French GL, Otter JA, Shannon KP, Adams NMT, Watling D, Parks MJ. Tackling contamination of the hospital environment by methicillin-resistant Staphylococcus aureus (MRSA): a comparison between conventional terminal cleaning and hydrogen peroxide vapour decontamination. J Hosp Infect. 2004;57:31–37.
    1. Otter JA, Yezli S, Perl TM, Barbut F, French GL. The role of ‘no-touch’ automated room disinfection systems in infection prevention and control. J Hosp Infect. 2013;83:1–13.
    1. Fu TY, Gent P, Kumar V. Efficacy, efficiency and safety aspects of hydrogen peroxide vapour and aerosolized hydrogen peroxide room disinfection systems. J Hosp Infect. 2012;80:199–205.
    1. Barbut F, Menuet D, Verachten M, Girou E. Comparison of the efficacy of a hydrogen peroxide dry-mist disinfection system and sodium hypochlorite solution for eradication of Clostridium difficile spores. Infect Control Hosp Epidemiol. 2009;30:507–514.
    1. Passaretti CL, Otter JA, Reich NG. An evaluation of environmental decontamination with hydrogen peroxide vapor for reducing the risk of patient acquisition of multidrug-resistant organisms. Clin Infect Dis. 2013;56:27–35.
    1. Schmidt MG, Cantey JR, Freeman KD. Sustained reduction of microbial burden on common hospital surfaces through introduction of copper. J Clin Microbiol. 2012;50:2217–2223.
    1. Schmidt MG, Attaway HH, III, Fairey SE, Steed LL, Michels HT, Salgado CD. Copper continuously limits the concentration of bacteria resident on bed rails within the intensive care unit. Infect Control Hosp Epidemiol. 2013;34:530–533.
    1. Casey AL, Elliott TSJ, Adams D. Role of copper in reducing hospital environment contamination. J Hosp Infect. 2010;74:72–77.
    1. Karpanen TJ, Casey AL, Lambert PA. The antimicrobial efficacy of copper alloy furnishing in the clinical environment: a crossover study. Infect Control Hosp Epidemiol. 2012;33:3–9.
    1. Salgado CD, Sepkowitz KA, John JF. Copper surfaces reduce the rate of healthcare-acquired infections in the intensive care unit. Infect Control Hosp Epidemiol. 2013;34:479–486.
    1. Mulvey D, Redding P, Robertson C. Finding a benchmark for monitoring hospital cleanliness. J Hosp Infect. 2011;77:25–30.
    1. Boyce JM, Havill NL, Dumigan DG, Golebiewski M, Balogun O, Rizvani R. Monitoring the effectiveness of hospital cleaning practices by use of an adenosine triphosphate bioluminescence assay. Infect Control Hosp Epidemiol. 2009;30:678–684.
    1. Lewis T, Griffith C, Gallo M, Weinbren M. A modified ATP benchmark for evaluating the cleaning of some hospital environmental surfaces. J Hosp Infect. 2008;69:156–163.
    1. Griffith CJ, Obee P, Cooper RA, Burton NF, Lewis M. The effectiveness of existing and modified cleaning regimens in a Welsh hospital. J Hosp Infect. 2007;66:352–359.
    1. Malik RE, Cooper RA, Griffith CJ. Use of audit tools to evaluate the efficacy of cleaning systems in hospitals. Am J Infect Control. 2003;31:181–187.
    1. World Health Organization . WHO Patient Safety. WHO guidelines on hand hygiene in health care. World Health Organization; Geneva: 2009.
    1. Gupta A, Della-Latta P, Todd B. Outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a neonatal intensive care unit linked to artificial nails. Infect Control Hosp Epidemiol. 2004;25:210–215.
    1. Pittet D, Dharan S, Touveneau S, Sauvan V, Perneger TV. Bacterial contamination of the hands of hospital staff during routine patient care. Arch Intern Med. 1999;159:821–826.
    1. Pessoa-Silva CL, Dharan S, Hugonnet S. Dynamics of bacterial hand contamination during routine neonatal care. Infect Control Hosp Epidemiol. 2004;25:192–197.
    1. Fendler EJ, Ali Y, Hammond BS, Lyons MK, Kelley MB, Vowell NA. The impact of alcohol hand sanitizer use on infection rates in an extended care facility. Am J Infect Control. 2002;30:226–233.
    1. Ryan MA, Christian RS, Wohlrabe J. Handwashing and respiratory illness among young adults in military training. Am J Prev Med. 2001;21:79–83.
    1. Pittet D, Hugonnet S, Harbarth S. Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Lancet. 2000;356:1307–1312.
    1. Gordin FM, Schultz ME, Huber RA, Gill JA. Reduction in nosocomial transmission of drug-resistant bacteria after introduction of an alcohol-based handrub. Infect Control Hosp Epidemiol. 2005;26:650–653.
    1. Boyce JM, Pittet D, Healthcare Infection Control Practices Advisory Committee, Society for Healthcare Epidemiology of America, Association for Professionals in Infection Control, Infectious Diseases Society of America Hand Hygiene Task Force Guideline for hand hygiene in health-care settings: recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Infect Control Hosp Epidemiol. 2002;23(Suppl. 12):S3–S40.
    1. Provincial Infectious Diseases Advisory Committee . Best practices for hand hygiene in all health care settings. Ontario Ministry of Health and Long-Term Care/Public Health Division; Toronto: 2010. Accessed July 20, 2013.
    1. Sax H, Allegranzi B, Uçkay I, Larson E, Boyce J, Pittet D. ‘My five moments for hand hygiene’: a user-centred design approach to understand, train, monitor and report hand hygiene. J Hosp Infect. 2007;67:9–21.
    1. National Clinical Guideline Centre . Infection: prevention and control of healthcare-associated infections in primary and community care: partial update of NICE Clinical Guideline 2. NICE Clinical Guidelines, No. 139. Royal College of Physicians; London: 2012.
    1. Pellowe C, Pratt R, Harper P. Infection control: prevention of healthcare-associated infection in primary and community care. J Hosp Infect. 2003;55(Suppl. 2):1–127.
    1. British Standards Institution Chemical disinfectants and antiseptics. Hygienic handrub. Test method and requirements (phase 2/step 2) 1997. Accessed August 15, 2013.
    1. Lucet JC, Rigaud MP, Mentre F. Hand contamination before and after different hand hygiene techniques: a randomized clinical trial. J Hosp Infect. 2002;50:276–280.
    1. Winnefeld M, Richard MA, Drancourt M, Grob JJ. Skin tolerance and effectiveness of two hand decontamination procedures in everyday hospital use. Br J Dermatol. 2000;143:546–550.
    1. Larson EL, Aiello AE, Bastyr J. Assessment of two hand hygiene regimens for intensive care unit personnel. Crit Care Med. 2001;29:944–951.
    1. Girou E, Loyeau S, Legrand P, Oppein F, Brun-Buisson C. Efficacy of handrubbing with alcohol based solution versus standard handwashing with antiseptic soap: randomised clinical trial. BMJ. 2002;325:362–365.
    1. Zaragoza M, Sallés M, Gomez J, Bayas JM, Trilla A. Handwashing with soap or alcoholic solutions? A randomized clinical trial of its effectiveness. Am J Infect Control. 1999;27:258–261.
    1. Larson EL, Cimiotti J, Haas J. Effect of antiseptic handwashing vs alcohol sanitizer on health care-associated infections in neonatal intensive care units. Arch Pediatr Adolesc Med. 2005;159:377–383.
    1. Herruzo-Cabrera R, Garcia-Caballero J, Martin-Moreno JM, Graciani-Perez-Regadera MA, Perez-Rodriguez J. Clinical assay of N-duopropenide alcohol solution on hand application in newborn and pediatric intensive care units: control of an outbreak of multiresistant Klebsiella pneumoniae in a newborn intensive care unit with this measure. Am J Infect Control. 2001;29:162–167.
    1. Herruzo-Cabrera R, Garcia-Caballero J, Fernandez-Acenero MJ. A new alcohol solution (N-duopropenide) for hygienic (or routine) hand disinfection is more useful than classic handwashing: in vitro and in vivo studies in burn and other intensive care units. Burns. 2001;27:747–752.
    1. Larson E, Silberger M, Jakob K. Assessment of alternative hand hygiene regimens to improve skin health among neonatal intensive care unit nurses. Heart Lung. 2000;29:136–142.
    1. Kramer A, Rudolph P, Kampf G, Pittet D. Limited efficacy of alcohol-based hand gels. Lancet. 2002;359:1489–1490.
    1. Moadab A, Rupley KF, Wadhams P. Effectiveness of a nonrinse, alcohol-free antiseptic hand wash. J Am Podiatr Med Assoc. 2001;91:288–293.
    1. Guilhermetti M, Hernandes SED, Fukushigue Y, Garcia LB, Cardoso CL. Effectiveness of hand-cleansing agents for removing methicillin-resistant Staphylococcus aureus from contaminated hands. Infect Control Hosp Epidemiol. 2001;22:105–108.
    1. Paulson DS, Fendler EJ, Dolan MJ, Williams RA. A close look at alcohol gel as an antimicrobial sanitizing agent. Am J Infect Control. 1999;27:332–338.
    1. Cardoso CL. Effectiveness of hand-cleansing agents for removing Acinetobacter baumannii strain from contaminated hands. Am J Infect Control. 1999;27:327–331.
    1. Kampf G, Jarosch R, Rüden H. Limited effectiveness of chlorhexidine based hand disinfectants against methicillin-resistant Staphylococcus aureus (MRSA) J Hosp Infect. 1998;38:297–303.
    1. Dyer DL, Gerenratch KB, Wadhams PS. Testing a new alcohol-free hand sanitizer to combat infection. AORN J. 1998;68:239–241. 243–244, 247–251.
    1. Dharan S, Hugonnet S, Sax H, Pittet D. Comparison of waterless hand antisepsis agents at short application times: raising the flag of concern. Infect Control Hosp Epidemiol. 2003;24:160–164.
    1. Sickbert-Bennett EE, Weber DJ, Gergen-Teague MF, Sobsey MD, Samsa GP, Rutala WA. Comparative efficacy of hand hygiene agents in the reduction of bacteria and viruses. Am J Infect Control. 2005;33:67–77.
    1. Gould DJ, Moralejo D, Drey N, Chudleigh JH. Interventions to improve hand hygiene compliance in patient care. Cochrane Database Syst Rev. 2011;8 CD005186.
    1. Sakamoto F, Yamada H, Suzuki C, Sugiura H, Tokuda Y. Increased use of alcohol-based hand sanitizers and successful eradication of methicillin-resistant Staphylococcus aureus from a neonatal intensive care unit: a multivariate time series analysis. Am J Infect Control. 2010;38:529–534.
    1. Faoagali JL, George N, Fong J, Davy J, Dowser M. Comparison of the antibacterial efficacy of 4% chlorhexidine gluconate and 1% triclosan handwash products in an acute clinical ward. Am J Infect Control. 1999;27:320–326.
    1. Oughton MT, Loo VG, Dendukuri N, Fenn S, Libman MD. Hand hygiene with soap and water is superior to alcohol rub and antiseptic wipes for removal of Clostridium difficile. Infect Control Hosp Epidemiol. 2009;30:939–944.
    1. Jabbar U, Leischner J, Kasper D. Effectiveness of alcohol-based hand rubs for removal of Clostridium difficile spores from hands. Infect Control Hosp Epidemiol. 2010;31:565–570.
    1. Grayson ML, Melvani S, Druce J. Efficacy of soap and water and alcohol-based hand-rub preparations against live H1N1 influenza virus on the hands of human volunteers. Clin Infect Dis. 2009;48:285–291.
    1. Turner RB, Fuls JL, Rodgers ND. Effectiveness of hand sanitizers with and without organic acids for removal of rhinovirus from hands. Antimicrob Agents Chemother. 2010;54:1363–1364.
    1. Chen Y, Sheng W, Wang J. Effectiveness and limitations of hand hygiene promotion on decreasing healthcare-associated infections. PLoS One. 2011;6:e27163.
    1. Department of Health . Uniforms and workwear: guidance on uniform and workwear policies for NHS employers. Department of Health; London: 2010.
    1. Chow A, Arah OA, Chan S. Alcohol handrubbing and chlorhexidine handwashing protocols for routine hospital practice: a randomized clinical trial of protocol efficacy and time effectiveness. Am J Infect Control. 2012;40:800–805.
    1. Kampf G, Reichel M, Feil Y, Eggerstedt S, Kaulfers P. Influence of rub-in technique on required application time and hand coverage in hygienic hand disinfection. BMC Infect Dis. 2008;8:149.
    1. Gustafson DR, Vetter EA, Larson DR. Effects of 4 hand-drying methods for removing bacteria from washed hands: a randomized trial. Mayo Clin Proc. 2000;75:705–708.
    1. Yamamoto Y, Ugai K, Takahashi Y. Efficiency of hand drying for removing bacteria from washed hands: comparison of paper towel drying with warm air drying. Infect Control Hosp Epidemiol. 2005;26:316–320.
    1. Department of Health . Infection control in the built environment. Health Building Note 00-09. Department of Health; London: 2013.
    1. Huang C, Ma W, Stack S. The hygienic efficacy of different hand-drying methods: a review of the evidence. Mayo Clin Proc. 2012;87:791–798.
    1. Pietsch H. Hand antiseptics: rubs versus scrubs, alcoholic solutions versus alcoholic gels. J Hosp Infect. 2001;48(Suppl. A):S33–S36.
    1. Boyce JM, Kelliher S, Vallande N. Skin irritation and dryness associated with two hand-hygiene regimens: soap-and-water hand washing versus hand antisepsis with an alcoholic hand gel. Infect Control Hosp Epidemiol. 2000;21:442–448.
    1. Forrester BG, Roth VS. Hand dermatitis in intensive care units. J Occup Environ Med. 1998;40:881–885.
    1. Kampf G, Muscatiello M. Dermal tolerance of Sterillium, a propanol-based hand rub. J Hosp Infect. 2003;55:295–298.
    1. Pittet D, Allegranzi B, Sax H. Double-blind, randomized, crossover trial of 3 hand rub formulations: fast-track evaluation of tolerability and acceptability. Infect Control Hosp Epidemiol. 2007;28:1344–1351.
    1. Becks VE, Lorenzoni NM. Pseudomonas aeruginosa outbreak in a neonatal intensive care unit: a possible link to contaminated hand lotion. Am J Infect Control. 1995;23:396–398.
    1. Hilburn J, Hammond BS, Fendler EJ, Groziak PA. Use of alcohol hand sanitizer as an infection control strategy in an acute care facility. Am J Infect Control. 2003;31:109–116.
    1. Rosenthal VD, Guzman S, Safdar N. Reduction in nosocomial infection with improved hand hygiene in intensive care units of a tertiary care hospital in Argentina. Am J Infect Control. 2005;33:392–397.
    1. Rosenthal VD, Guzman S, Safdar N. Effect of education and performance feedback on rates of catheter-associated urinary tract infection in intensive care units in Argentina. Infect Control Hosp Epidemiol. 2004;25:47–50.
    1. Won S, Chou H, Hsieh W. Handwashing program for the prevention of nosocomial infections in a neonatal intensive care unit. Infect Control Hosp Epidemiol. 2004;25:742–746.
    1. MacDonald A, Dinah F, MacKenzie D, Wilson A. Performance feedback of hand hygiene, using alcohol gel as the skin decontaminant, reduces the number of inpatients newly affected by MRSA and antibiotic costs. J Hosp Infect. 2004;56:56–63.
    1. Wendt C, Knautz D, von Baum H. Differences in hand hygiene behavior related to the contamination risk of healthcare activities in different groups of healthcare workers. Infect Control Hosp Epidemiol. 2004;25:203–206.
    1. Cohen B, Saiman L, Cimiotti J, Larson E. Factors associated with hand hygiene practices in two neonatal intensive care units. Pediatr Infect Dis J. 2003;22:494–499.
    1. Brown SM, Lubimova AV, Khrustalyeva NM. Use of an alcohol-based hand rub and quality improvement interventions to improve hand hygiene in a Russian neonatal intensive care unit. Infect Control Hosp Epidemiol. 2003;24:172–179.
    1. Kuzu N, Özer F, Aydemir S, Yalcin AN, Zencir M. Compliance with hand hygiene and glove use in a university-affiliated hospital. Infect Control Hosp Epidemiol. 2005;26:312–315.
    1. Kim PW, Roghmann M, Perencevich EN, Harris AD. Rates of hand disinfection associated with glove use, patient isolation, and changes between exposure to various body sites. Am J Infect Control. 2003;31:97–103.
    1. McGuckin M, Taylor A, Martin V, Porten L, Salcido R. Evaluation of a patient education model for increasing hand hygiene compliance in an inpatient rehabilitation unit. Am J Infect Control. 2004;32:235–238.
    1. McGuckin M, Waterman R, Storr IJ. Evaluation of a patient-empowering hand hygiene programme in the UK. J Hosp Infect. 2001;48:222–227.
    1. Naikoba S, Hayward A. The effectiveness of interventions aimed at increasing handwashing in healthcare workers - a systematic review. J Hosp Infect. 2001;47:173–180.
    1. Magiorakos AP, Leens E, Michael S. National hand hygiene campaigns in Europe, 2000–2009. Euro surveillance: bulletin Européen sur les maladies transmissibles. Eur Communic Dis Bull. 2009;14:17.
    1. Grayson ML, Russo PL, Cruickshank M. Outcomes from the first 2 years of the Australian national hand hygiene initiative. Med J Aust. 2011;195:615–619.
    1. Gould DJ, Chudleigh JH, Moralejo D, Drey N. Interventions to improve hand hygiene compliance in patient care. Cochrane Database Syst Rev. 2007;18 CD005186.
    1. Backman C, Zoutman DE, Marck PB. An integrative review of the current evidence on the relationship between hand hygiene interventions and the incidence of health care-associated infections. Am J Infect Control. 2008;36:333–348.
    1. Aboelela SW, Stone PW, Larson EL. Effectiveness of bundled behavioural interventions to control healthcare-associated infections: a systematic review of the literature. J Hosp Infect. 2007;66:101–108.
    1. Cherry MG, Brown JM, Bethell GS, Neal T, Shaw NJ. Features of educational interventions that lead to compliance with hand hygiene in healthcare professionals within a hospital care setting. A BEME systematic review: BEME Guide No. 22. Med Teach. 2012;34:e406–e420.
    1. Huis A, Schoonhoven L, Grol R, Donders R, Hulscher M, van Achterberg T. Impact of a team and leaders-directed strategy to improve nurses' adherence to hand hygiene guidelines: a cluster randomised trial. Int J Nurs Stud. 2013;50:464–474.
    1. Huis A, Holleman G, van Achterberg T, Grol R, Schoonhoven L, Hulscher M. Explaining the effects of two different strategies for promoting hand hygiene in hospital nurses: a process evaluation alongside a cluster randomised controlled trial. Implement Sci. 2013;8:41.
    1. Fuller C, Duckworth G, Jeanes A. The Feedback Intervention Trial (FIT) – improving hand-hygiene compliance in UK healthcare workers: a stepped wedge cluster randomised controlled trial. PLoS One. 2012;7:e41617.
    1. Stone SP, Jeanes A, Roberts J. Evaluation of the national Cleanyourhands campaign to reduce Staphylococcus aureus bacteraemia and Clostridium difficile infection in hospitals in England and Wales by improved hand hygiene: four year, prospective, ecological, interrupted time series study. BMJ. 2012;3:e3005.
    1. Benning A, Carmalt M, Rudge G. Multiple component patient safety intervention in English hospitals: controlled evaluation of second phase. BMJ. 2011;342:d199.
    1. Longtin Y, Sax H, Allegranzi B, Hugonnet S, Pittet D. Patients' beliefs and perceptions of their participation to increase healthcare worker compliance with hand hygiene. Infect Control Hosp Epidemiol. 2009;30:830–839.
    1. Lent V, Eckstein BC, Eckstein EC, Cameron AS, Budavich R, Donskey CJ. Evaluation of patient participation in a patient empowerment initiative to improve hand hygiene practices in a veterans affairs medical center. Am J Infect Control. 2009;37:117–120.
    1. Sanderson PJ, Weissler S. Recovery of coliforms from the hands of nurses and patients: activities leading to contamination. J Hosp Infect. 1992;21:85–93.
    1. Larson EL, Cronquist AB, Whittier S, Lai L, Lyle CT, Latta PD. Differences in skin flora between inpatients and chronically ill outpatients. Heart Lung. 2000;29:298–305.
    1. Banfield KR, Kerr KG. Could hospital patients' hands constitute a missing link? J Hosp Infect. 2005;61:183–188.
    1. Savage J, Fuller C, Besser S, Stone S. Use of alcohol hand rub (AHR) at ward entrances and use of soap and AHR by patients and visitors: a study in 27 wards in nine acute NHS trusts. J Infect Prev. 2011;12:54–58.
    1. Lawrence M. Patient hand hygiene: a clinical inquiry. Nurs Times. 1983;79:24–25.
    1. Duncan C. An exploratory study of patient's feelings about asking healthcare professionals to wash their hands. J Ren Care. 2007;33:30–34.
    1. Burnett E, Lee K, Kydd P. Hand hygiene: what about our patients? Br J Infect Contr. 2008;9:19–24.
    1. Burnett E. Perceptions, attitudes, and behavior towards patient hand hygiene. Am J Infect Control. 2009;37:638–642.
    1. Cheng VCC, Wu AKL, Cheung CHY. Outbreak of human metapneumovirus infection in psychiatric inpatients: implications for directly observed use of alcohol hand rub in prevention of nosocomial outbreaks. J Hosp Infect. 2007;67:336–343.
    1. Chen YC, Chiang LC. Effectiveness of hand-washing teaching programs for families of children in paediatric intensive care units. J Clin Nurs. 2007;16:1173–1179.
    1. Gagné D, Bédard G, Maziade PJ. Systematic patients' hand disinfection: impact on meticillin-resistant Staphylococcus aureus infection rates in a community hospital. J Hosp Infect. 2010;75:269–272.
    1. Expert Advisory Group on AIDS and the Advisory Group on Hepatitis . Guidance for clinical healthcare workers: protection against infection with bloodborne viruses. Department of Health; London: 1998.
    1. Wilson JA, Loveday HP, Hoffman PN, Pratt RJ. Uniform: an evidence review of the microbiological significance of uniforms and uniform policy in the prevention and control of healthcare-associated infections. Report to the Department of Health (England) J Hosp Infect. 2007;66:301–307.
    1. Health and Safety Executive . Management of Health and Safety at Work Regulations. HSE Books; London: 1999.
    1. Health and Safety Executive . Personal protective equipment at work. Personal Protective Equipment at Work Regulations 1992 (as amended): guidance on regulations. 2nd ed. HSE Books; London: 2005.
    1. Health and Safety Commission . Control of substances hazardous to health. Control of Substances Hazardous to Health Regulations 2002 (as amended). Approved code of practice and guidance. 5th ed. HSE Books; London: 2002.
    1. Health and Safety Executive . Personal protective equipment (PPE) at work: a brief guide. INDG174 (rev2) HSE Books; London: 2013. Accessed June 5, 2013.
    1. Sax H, Perneger T, Hugonnet S, Herrault P, Chraïti M, Pittet D. Knowledge of standard and isolation precautions in a large teaching hospital. Infect Control Hosp Epidemiol. 2005;26:298–304.
    1. Trim JC, Adams D, Elliott TSJ. Healthcare workers' knowledge of inoculation injuries and glove use. Br J Nurs. 2003;12:215–221.
    1. Ferguson KJ, Waitzkin H, Beekmann SE, Doebbeling BN. Critical incidents of nonadherence with standard precautions guidelines among community hospital-based health care workers. J Gen Intern Med. 2004;19:726–731.
    1. Prieto J. Contact precautions for Clostridium diffcile and methicillin-resistant Staphylococcus aureus (MRSA): assessing the impact of a supportive intervention to improve practice. J Res Nurs. 2005;10:511–526.
    1. Royal College of Nursing . Tools of the trade; RCN guidance for healthcare staff on glove use and prevention of contact dermatitis. Royal College of Nursing; London: 2012. Accessed July 22, 2013.
    1. Health and Safety Executive . Selecting latex gloves. HSE Books; London: 2013. Accessed July 25, 2013.
    1. Health and Safety Executive . Choosing the right gloves to protect skin: a guide for employers. HSE Books; London: 2013. Accessed July 25, 2013.
    1. Fuller C, Savage J, Besser S. “The dirty hand in the latex glove”: a study of hand hygiene compliance when gloves are worn. Infect Control Hosp Epidemiol. 2011;32:1194–1199.
    1. Eveillard M, Guilloteau V, Kempf M. Impact of improving glove usage on the hand hygiene compliance. Am J Infect Control. 2011;39:608–610.
    1. Eveillard M, Raymond F, Joly-Guillou M. Measurement of hand hygiene compliance and gloving practices in different settings for the elderly considering the location of hand hygiene opportunities during patient care. Am J Infect Control. 2011;39:339–341.
    1. Katherason SG, Naing L, Jaalam K. Hand decontamination practices and the appropriate use of gloves in two adult intensive care units in Malaysia. J Infect Dev Ctries. 2010;4:118–123.
    1. Huskins WC, Samore M, Wallace D. Intervention to reduce transmission of resistant bacteria in intensive care. N Engl J Med. 2011;364:1407–1418.
    1. British Standards Institution . Medical gloves for single use. Part 1: Specification for freedom from holes. British Standards Institution; London: 2000. BS-EN 455–1.
    1. British Standards Institution . Medical gloves for single use. Part 2: Specification for physical properties. British Standards Institution; London: 2000. BS-EN 455–2.
    1. British Standards Institution . Medical gloves for single use. Part 3: Requirements and testing for biological evaluation. British Standards Institution; London: 2000. BS-EN 455–3.
    1. Tenorio AR, Badri SM, Sahgal NB. Effectiveness of gloves in the prevention of hand carriage of vancomycin-resistant enterococcus species by health care workers after patient care. Clin Infect Dis. 2001;32:826–829.
    1. Department of Health . Health Technical Memorandum 07-01: safe management of healthcare waste. Department of Health; London: 2013.
    1. Korniewicz D, El-Masri M, Broyles J. To determine the effects of gloves stress, type of material (vinyl, nitrile, copolymer, latex) and manufacturer on the barrier effectiveness of medical examination gloves. Am J Infect Control. 2002;30:133–138.
    1. Siegel JD, Rhinehart E, Jackson M, Chiarello L, the Healthcare Infection Control Practices Advisory Committee . 2007 Guideline for isolation precautions: preventing transmission of infectious agents in health care settings. Mosby, Inc; United States: 2007.
    1. Nye KJ, Leggett VA, Watterson L. Provision and decontamination of uniforms in the NHS. Nurs Stand. 2005;19:41–45.
    1. Speers R, Jr, Shooter RA, Gaya H, Patel N. Contamination of nurses' uniforms with Staphylococcus aureus. Lancet. 1969;2:233–235.
    1. Babb JR, Davies JG, Ayliffe GA. Contamination of protective clothing and nurses' uniforms in an isolation ward. J Hosp Infect. 1983;4:149–157.
    1. Callaghan I. Bacterial contamination of nurses' uniforms: a study. Nurs Stand. 1998;13:37–42.
    1. Perry C, Marshall R, Jones E. Bacterial contamination of uniforms. J Hosp Infect. 2001;48:238–241.
    1. Wong D, Nye K, Hollis P. Microbial flora on doctors' white coats. BMJ. 1991;303:1602–1604.
    1. Loh W, Ng VV, Holton J. Bacterial flora on the white coats of medical students. J Hosp Infect. 2000;45:65–68.
    1. Hambraeus A. Transfer of Staphylococcus aureus via nurses' uniforms. J Hyg. 1973;71:799–814.
    1. Barrie D, Wilson JA, Hoffman PN, Kramer JM. Bacillus cereus meningitis in two neurosurgical patients: an investigation into the source of the organism. J Infect. 1992;25:291–297.
    1. Barrie D, Hoffman PN, Wilson JA, Kramer JM. Contamination of hospital linen by Bacillus cereus. Epidemiol Infect. 1994;113:297–306.
    1. Zachary KC, Bayne PS, Morrison VJ, Ford DS, Silver LC, Hooper DC. Contamination of gowns, gloves, and stethoscopes with vancomycin-resistant enterococci. Infect Control Hosp Epidemiol. 2001;22:560–564.
    1. Webster J, Pritchard MA. Gowning by attendants and visitors in newborn nurseries for prevention of neonatal morbidity and mortality. Cochrane Database Syst Rev. 2003;3 CD003670.
    1. Puzniak LA, Leet T, Mayfield J, Kollef M, Mundy LM. To gown or not to gown: the effect on acquisition of vancomycin-resistant enterococci. Clin Infect Dis. 2002;35:18–25.
    1. Srinivasan A, Song X, Ross T, Merz W, Brower R, Perl TM. A prospective study to determine whether cover gowns in addition to gloves decrease nosocomial transmission of vancomycin-resistant enterococci in an intensive care unit. Infect Control Hosp Epidemiol. 2002;23:424–428.
    1. National Collaborating Centre for Chronic Conditions . Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control. Royal College of Physicians; London: 2006.
    1. Department of Health . Pandemic (H1N1) 2009 influenza. A summary of guidance for infection control in healthcare settings. Department of Health; London: 2009.
    1. Department of Health . The Interdepartmental Working Group on Tuberculosis: the prevention and control of tuberculosis in the United Kingdom. Department of Health; London: 1998.
    1. Health and Safety Executive . Respiratory protective equipment at work: a practical guide. 4th ed. HSE Books; London: 2013. HSG 53.
    1. Jefferson T, Del Mar C, Dooley L. Physical interventions to interrupt or reduce the spread of respiratory viruses. Cochrane Database Syst Rev. 2010;1 CD006207.
    1. Cowling BJ, Zhou Y, Ip DK, Leung GM, Aiello AE. Face masks to prevent transmission of influenza virus: a systematic review. Epidemiol Infect. 2010;138:449–456.
    1. Gralton J, McLaws ML. Protecting healthcare workers from pandemic influenza: N95 or surgical masks? Crit Care Med. 2010;38:657–667.
    1. Bin-Reza F, Lopez Chavarrias V, Nicoll A, Chamberland ME. The use of masks and respirators to prevent transmission of influenza: a systematic review of the scientific evidence. Influenza Other Respir Viruses. 2012;6:257–267.
    1. Health and Safety Commission . Control of Substances Hazardous to Health Regulations. Approved codes of practice. HSE Books; London: 1999. p. 75.
    1. Health and Safety Executive . Health and Safety at Work Act 1974. HMSO; London: 1994. Accessed August 1, 2013.
    1. Health and Safety Executive Health and Safety (Sharp Instruments in Healthcare) Regulations 2013. Guidance for employers and employees. Health Services Information Sheet 7. 2013. Accessed July 25, 2013.
    1. Health and Safety Executive The Provision and Use of Work Equipment Regulations. 1998. Accessed August 1, 2013.
    1. Health and Safety Executive . The Reporting of Injuries, Diseases and Dangerous Occurrences Regulations 1995. HSE Books; London: 1995.
    1. Health and Safety Executive . Personal protective equipment at work: Personal Protective Equipment at Work Regulations. HMSO; London: 1992.
    1. Health and Safety Executive . The Health and Safety (First-Aid) Regulations 1981. Approved code of practice and guidance. HSE Books; London: 1981.
    1. National Audit Office . A safer place to work: improving the management of health and safety risks to staff in NHS trusts. The Stationery Office; London: 2003.
    1. Ball J, Pike G, Royal College of Nursing . Needlestick injury in 2008: results from a survey of RCN members. Royal College of Nursing; London: 2008.
    1. Health Protection Agency, Centre for Infections . Eye of the needle: United Kingdom surveillance of significant occupational exposures to bloodborne viruses in healthcare workers. Health Protection Agency; London: 2008.
    1. Yazdanpanah Y, Domart M, Tarantola A. Risk factors for hepatitis C virus transmission to health care workers after occupational exposure: a European case-control study. Clin Infect Dis. 2005;41:1423–1430.
    1. Department of Health . HIV Post-exposure prophylaxis: guidance from the UK Chief Medical Officers' Expert Advisory Group on AIDS. Department of Health; London: 2008.
    1. Centers for Disease Control Update. Universal precautions for prevention of transmission of human immunodeficiency virus, hepatitis B virus and other bloodborne pathogens in health care settings. MMWR. 1988;37:377–382. 387–388.
    1. Occupational Safety and Health Administration . Enforcement procedures for the occupational exposure to bloodborne pathogens. Directive number CPL2–2.44D. OSHA; Washington DC: 1999. Accessed August 6, 2013.
    1. Council Directive 2010/32/EU Implementing the framework agreement on prevention from sharps injuries in the hospital and health care sector. Concluded by HOSPEEM and EPSU. OJEU. 2010;L:66–72.
    1. Health and Safety Executive An evaluation of the efficacy of safer sharps devices. Systematic review. 2012. Accessed July 25, 2013.
    1. Brusaferro S, Calligaris L, Farneti F, Gubian F, Londero C, Baldo V. Educational programmes and sharps injuries in health care workers. Occup Med (Lond) 2009;59:512–514.
    1. Valls V, Lozano MS, Yánez R. Use of safety devices and the prevention of percutaneous injuries among healthcare workers. Infect Control Hosp Epidemiol. 2007;28:1352–1360.
    1. Adams D, Elliott TSJ. Impact of safety needle devices on occupationally acquired needlestick injuries: a four-year prospective study. J Hosp Infect. 2006;64:50–55.
    1. Zakrzewska JM, Greenwood I, Jackson J. Introducing safety syringes into a UK dental school – a controlled study. Br Dent J. 2001;190:88–92.
    1. Yang Y, Liou S, Chen C. The effectiveness of a training program on reducing needlestick injuries/sharp object injuries among soon graduate vocational nursing school students in Southern Taiwan. J Occup Health. 2007;49:424–429.
    1. Department of Health . An organisation with a memory. Stationery Office; London: 2000.
    1. National Health Service Employees . The management of health safety and welfare: issues for NHS staff. Stationery Office; London: 2005.
    1. ECRI Institute . Sharps safety and needlestick prevention. 2nd ed. ECRI; Plymouth: 2003.
    1. Asai T, Hidaka I, Kawashima A, Miki T, Inada K, Kawachi S. Efficacy of catheter needles with safeguard mechanisms. Anaesthesia. 2002;57:572–577.
    1. Sohn S, Eagan J, Sepkowitz KA, Zuccotti G. Effect of implementing safety-engineered devices on percutaneous injury epidemiology. Infect Control Hosp Epidemiol. 2004;25:536–542.
    1. Alvarado-Ramy F, Solomon R, Fahrner R. A comprehensive approach to percutaneous injury prevention during phlebotomy: results of a multicenter study, 1993–1995. Infect Control Hosp Epidemiol. 2003;24:97–104.
    1. Rogues A, Verdun-Esquer C, Buisson-Valles I. Impact of safety devices for preventing percutaneous injuries related to phlebotomy procedures in health care workers. Am J Infect Control. 2004;32:441–444.
    1. Mendelson MH, Lin-Chen BY, Solomon R, Bailey E, Kogan G, Goldbold J. Evaluation of a safety resheathable winged steel needle for prevention of percutaneous injuries associated with intravascular-access procedures among healthcare workers. Infect Control Hosp Epidemiol. 2003;24:105–112.
    1. Adams D, Elliott TSJ. A comparative user evaluation of three needle-protective devices. Br J Nurs. 2003;12:470–474.
    1. Cullen BL, Genasi F, Symington I. Potential for reported needlestick injury prevention among healthcare workers through safety device usage and improvement of guideline adherence: expert panel assessment. J Hosp Infect. 2006;63:445–451.
    1. Centers for Disease Control Evaluation of safety devices for preventing percutaneous injuries among health care workers during phlebotomy procedures – Minneapolis-St Paul, New York City and San Francisco, 1993–1995. MMWR. 1997;46:21–25.
    1. Sullivan S, Williamson B, Wilson LK, Korte JE, Soper D. Blunt needles for the reduction of needlestick injuries during cesarean delivery: a randomized controlled trial. Obstet Gynecol. 2009;114:211.
    1. Hotaling M. A retractable winged steel (butterfly) needle performance improvement project. Jt Comm J Qual Patient Saf. 2009;35:100–105.
    1. Lamontagne F, Abiteboul D, Lolom I. Role of safety-engineered devices in preventing needlestick injuries in 32 French hospitals. Infect Control Hosp Epidemiol. 2007;28:18–23.
    1. Azar-Cavanagh M, Burdt P, Green-McKenzie J. Effect of the introduction of an engineered sharps injury prevention device on the percutaneous injury rate in healthcare workers. Infect Control Hosp Epidemiol. 2007;28:165–170.
    1. Sohn S, Eagan J, Sepkowitz KA. Safety-engineered device implementation: does it introduce bias in percutaneous injury reporting? Infect Control Hosp Epidemiol. 2004;25:543–547.
    1. McCleary J, Caldero K, Adams T. Guarded fistula needle reduces needlestick injuries in hemodialysis. Nephrol News Issues. 2002;16:66–70.
    1. Rogers B, Goodno L. Evaluation of interventions to prevent needlestick injuries in health care occupations. Am J Prev Med. 2000;18:90–98.
    1. Reddy SG, Emery RJ. Assessing the effect of long-term availability of engineering controls on needlestick injuries among health care workers: a 3-year preimplementation and postimplementation comparison. Am J Infect Control. 2001;29:425–427.
    1. Prunet B, Meaudre E, Montcriol A. A prospective randomized trial of two safety peripheral intravenous catheters. Anesth Analg. 2008;107:155–158.
    1. Bamberg R, Rivers C, Moore C. Use of needle safety devices by clinical laboratories in North Carolina hospitals. Clin Leadersh Manag Rev. 2003;17:21–25.
    1. Casey AL, Elliott TS. The usability and acceptability of a needleless connector system. Br J Nurs. 2007;16:267–271.
    1. Clarke SP, Rockett JL, Sloane DM, Aiken LH. Organizational climate, staffing, and safety equipment as predictors of needlestick injuries and near-misses in hospital nurses. Am J Infect Control. 2002;30:207–216.
    1. National Institute for Occupational Safety and Health . Preventing needlestick injuries in health care settings. Department of Health and Human Services; Cincinnati: 1999.
    1. Wilson J. Infection control in clinical practices. Bailliere Tindall; London: 2006.
    1. Cherry MG, Brown JM, Neal T, Ben Shaw N. What features of educational interventions lead to competence in aseptic insertion and maintenance of CV catheters in acute care? BEME Guide No. 15. Med Teach. 2010;32:198. 198.
    1. Rowley S, Clare S, Macqueen S, Molyneux R. ANTT v2: an updated practice framework for aseptic technique. Br J Nurs. 2010;19(Suppl.):S5–S11.
    1. Gould CV, Umscheid CA, Agarwal RK, Kuntz G, Pegues DA, Healthcare Infection Control Practices Advisory Committee Guideline for prevention of catheter-associated urinary tract infections. Infect Control Hosp Epidemiol. 2010;31:319–326.
    1. Health Protection Agency English national point prevalence survey on healthcare associated infections and antimicrobial use, 2011: preliminary data. 2012. Accessed July 25, 2013.
    1. Smyth ETM, McIlvenny G, Enstone JE. Four country healthcare associated infection prevalence survey 2006: overview of the results. J Hosp Infect. 2008;69:230–248.
    1. Department of Health . Urinary catheter care. Essential steps to safe, clean care: reducing healthcare associated infections. Department of Health; London: 2006.
    1. Chenoweth C, Saint S. Preventing catheter-associated urinary tract infections in the intensive care unit. Crit Care Clin. 2013;29:19–32.
    1. Johnson JR, Kuskowski MA, Wilt TJ. Systematic review: antimicrobial urinary catheters to prevent catheter-associated urinary tract infection in hospitalized patients. Ann Intern Med. 2006;144:116–126.
    1. Warren JW, Tenney JH, Hoopes JM, Muncie HL, Anthony WC. A prospective microbiologic study of bacteriuria in patients with chronic indwelling urethral catheters. J Infect Dis. 1982;146:719–723.
    1. Warren JW. Catheter-associated urinary tract infections. Int J Antimicrob Agents. 2001;17:299–303.
    1. Saint S, Wiese J, Amory JK. Are physicians aware of which of their patients have indwelling urinary catheters? Am J Med. 2000;109:476–480.
    1. Munasinghe RL, Yazdani H, Siddique M, Hafeez W. Appropriateness of use of indwelling urinary catheters in patients admitted to the medical service. Infect Control Hosp Epidemiol. 2001;22:647–649.
    1. Jain P, Parada JP, David A, Smith LG. Overuse of the indwelling urinary tract catheter in hospitalized medical patients. Arch Intern Med. 1995;155:1425–1429.
    1. Burton DC, Edwards JR, Srinivasan A, Fridkin SK, Gould CV. Trends in catheter-associated urinary tract infections in adult intensive care units – United States, 1990–2007. Infect Control Hosp Epidemiol. 2011;32:748–756.
    1. Saint S. Clinical and economic consequences of nosocomial catheter-related bacteriuria. Am J Infect Control. 2000;28:68–75.
    1. Shuman EK, Chenoweth CE. Recognition and prevention of healthcare-associated urinary tract infections in the intensive care unit. Crit Care Med. 2010;38(Suppl.):S373–S379.
    1. Chang R, Todd Greene M, Chenoweth CE. Epidemiology of hospital-acquired urinary tract-related bloodstream infection at a university hospital. Infect Control Hosp Epidemiol. 2011;32:1127–1129.
    1. Beattie M, Taylor J. Silver alloy vs. uncoated urinary catheters: a systematic review of the literature. J Clin Nurs. 2011;20:2098–2108.
    1. Ha U, Cho Y. Catheter-associated urinary tract infections: new aspects of novel urinary catheters. Int J Antimicrob Agents. 2006;28:485–490.
    1. Bernard MS, Hunter KF, Moore KN. A review of strategies to decrease the duration of indwelling urethral catheters and potentially reduce the incidence of catheter-associated urinary tract infections. Urol Nurs. 2012;32:29–37.
    1. Saint S, Savel RH, Matthay MA. Enhancing the safety of critically ill patients by reducing urinary and central venous catheter-related infections. Am J Respir Crit Care Med. 2002;165:1475–1479.
    1. Talja M, Korpela A, Jarvi K. Comparison of urethral reaction to full silicone, hydrogen-coated and siliconised latex catheters. Br J Urol. 1990;66:652–657.
    1. Robertson GS, Everitt N, Burton PR, Flynn JT. Effect of catheter material on the incidence of urethral strictures. Br J Urol. 1991;68:612–617.
    1. Crowe H, Clift R, Duggan G, Bolton DM, Costello AJ. Randomised study of the effect of midnight versus 0600 removal of urinary catheters. Br J Urol. 1993;71:306–308.
    1. Hazelett S, Tsai M, Gareri M, Allen K. The association between indwelling urinary catheter use in the elderly and urinary tract infection in acute care. BMC Geriatr. 2006;6:15.
    1. Curran E, Murdoch H. Aiming to reduce catheter associated urinary tract infections (CAUTI) by adopting a checklist and bundle to achieve sustained system improvements. J Infect Prev. 2009;10:57–61.
    1. Davenport K, Keeley FX. Evidence for the use of silver-alloy-coated urethral catheters. J Hosp Infect. 2005;60:298–303.
    1. Ward L, Fenton K, Maher L. The high impact actions for nursing and midwifery 5: protection from infection. Nurs Times. 2010;106:20–21.
    1. Saint S, Lipsky BA. Preventing catheter-related bacteriuria: should we? Can we? How? Arch Intern Med. 1999;159:800–808.
    1. Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Dis Mon. 2003;49:53–70.
    1. Wong ES. Guideline for prevention of catheter-associated urinary tract infections. Am J Infect Control. 1983;11:28–36.
    1. Cornia PB, Amory JK, Fraser S, Saint S, Lipsky BA. Computer-based order entry decreases duration of indwelling urinary catheterization in hospitalized patients. Am J Med. 2003;114:404–407.
    1. Fakih MG, Dueweke C, Meisner S. Effect of nurse-led multidisciplinary rounds on reducing the unnecessary use of urinary catheterization in hospitalized patients. Infect Control Hosp Epidemiol. 2008;29:815–819.
    1. Meddings J, Rogers MAM, Macy M, Saint S. Systematic review and meta-analysis: reminder systems to reduce catheter-associated urinary tract infections and urinary catheter use in hospitalized patients. Clin Infect Dis. 2010;51:550–560.
    1. Loeb M, Hunt D, O'Halloran K, Carusone SC, Dafoe N, Walter SD. Stop orders to reduce inappropriate urinary catheterization in hospitalized patients: a randomized controlled trial. J Gen Intern Med. 2008;23:816–820.
    1. Stéphan F, Sax H, Wachsmuth M, Hoffmeyer P, Clergue F, Pittet D. Reduction of urinary tract infection and antibiotic use after surgery: a controlled, prospective, before-after intervention study. Clin Infect Dis. 2006;42:1544–1551.
    1. Murphy C, Fader M, Prieto J. Interventions to minimise the initial use of indwelling urinary catheters in acute care: a systematic review. Int J Nurs Stud. 2013 in press.
    1. Slappendel R, Weber EW. Non-invasive measurement of bladder volume as an indication for bladder catheterization after orthopaedic surgery and its effect on urinary tract infections. Eur J Anaesthesiol. 1999;16:503–506.
    1. Patrizzi K, Fasnacht A, Manno M. A collaborative, nurse-driven initiative to reduce hospital-acquired urinary tract infections. J Emerg Nurs. 2009;35:536–539.
    1. Topal J, Conklin S, Camp K, Morris V, Balcezak T, Herbert P. Prevention of nosocomial catheter-associated urinary tract infections through computerized feedback to physicians and a nurse-directed protocol. Am J Med Qual. 2005;20:121–126.
    1. Pomfret I. Continence clinic. Catheters: design, selection and management. Br J Nurs. 1996;5:245–251.
    1. Kunin C. Urinary tract infections: detection, prevention and management. 5th ed. Williams and Wilkins; Baltimore: 1997.
    1. Dieckhaus K, Garibaldi R. Prevention of catheter-associated urinary tract infections. In: Abrutytn E, Goldmann D, Scheckler W, editors. Saunders infection control reference service. W.B. Saunders Co; Philadelphia: 1998. pp. 169–174.
    1. Roe B, Brocklehurst J. Study of patients with indwelling catheters. J Adv Nurs. 1987;12:713–718.
    1. National Patient Safety Agency. Rapid response report: female urinary catheters causing trauma to adult males. NSPCA/2009/RRR02. 2009.
    1. Lopez-Lopez G, Pascual A, Martinez-Martinez L, Perea EJ. Effect of a siliconized latex urinary catheter on bacterial adherence and human neutrophil activity. Diagn Microbiol Infect Dis. 1991;14:1–6.
    1. Nickel JC, Feero P, Costerton JW, Wilson E. Incidence and importance of bacteriuria in postoperative, short-term urinary catheterization. Can J Surg. 1989;32:131–132.
    1. Schumm K, Lam T. Types of urethral catheters for management of short-term voiding problems in hospitalized adults: a short version Cochrane Review. Sri Lanka J Obstet Gynaecol. 2010;31:110–121.
    1. Chene G, Boulard G, Gachie JP. A controlled trial of a new material for coating urinary catheters. Agressologie. 1990;31:499–501.
    1. Tidd MJ, Gow JG, Pennington JH, Shelton J, Scott MR. Comparison of hydrophilic polymer-coated latex, uncoated latex and PVC indwelling balloon catheters in the prevention of urinary infection. Br J Urol. 1976;48:285–291.
    1. Pellowe C, Pratt R, Loveday H, Harper P, Robinson N, Jones SRLJ. The epic project: updating the evidence base for national evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England. A report with recommendations. J Hosp Infect. 2005;59:373–374.
    1. Brosnahan J, Jull A, Tracy C. Types of urethral catheters for management of short-term voiding problems in hospitalised adults. Cochrane Database Syst Rev. 2004;1 CD004013.
    1. Saint S, Elmore JG, Sullivan SD, Emerson SS, Koepsell TD. The efficacy of silver alloy-coated urinary catheters in preventing urinary tract infection: a meta-analysis. Am J Med. 1998;105:236–241.
    1. Dunn S, Pretty L, Reid H, Evans D. Management of short term indwelling urethral catheters to prevent urinary tract infections. A systematic review. Adelaide, S. Australia: Joanna Briggs Institute for Evidence Based Nursing and Midwifery. Systematic Review. 2000;6
    1. Niël-Weise BS, Arend SM, van den Broek PJ. Is there evidence for recommending silver-coated urinary catheters in guidelines? J Hosp Infect. 2002;52:81–87.
    1. Verleyen P, De Ridder D, Van Poppel H, Baert L. Clinical application of the Bardex IC Foley catheter. Eur Urol. 1999;36:240–246.
    1. Karchmer TB, Giannetta ET, Muto CA, Strain BA, Farr BM. A randomized crossover study of silver-coated urinary catheters in hospitalized patients. Arch Intern Med. 2000;160:3294–3298.
    1. Saint S, Veenstra DL, Sullivan SD, Chenoweth C, Fendrick AM. The potential clinical and economic benefits of silver alloy urinary catheters in preventing urinary tract infection. Arch Intern Med. 2000;160:2670–2675.
    1. Newton T, Still JM, Law E. A comparison of the effect of early insertion of standard latex and silver-impregnated latex Foley catheters on urinary tract infections in burn patients. Infect Control Hosp Epidemiol. 2002;23:217–218.
    1. Gentry H, Cope S. Using silver to reduce catheter-associated urinary tract infections. Nurs Stand. 2005;19:51–54.
    1. Madeo M, Davies D, Johnson G, Owen E, Wadsworth P, Martin C. The impact of using silver alloy urinary catheters in reducing the incidence of urinary tract infections in the critical care setting. Br J Infect Contr. 2004;5:21–24.
    1. Rupp ME, Fitzgerald T, Marion N. Effect of silver-coated urinary catheters: efficacy, cost-effectiveness, and antimicrobial resistance. Am J Infect Control. 2004;32:445–450.
    1. Chaiban G, Hanna H, Dvorak T, Raad I. A rapid method of impregnating endotracheal tubes and urinary catheters with gendine: a novel antiseptic agent. J Antimicrob Chemother. 2005;55:51–56.
    1. Cho YW, Park JH, Kim SH. Gentamicin-releasing urethral catheter for short-term catheterization. J Biomater Sci Polym Ed. 2003;14:963–972.
    1. Thibon P, Le Coutour X, Leroyer R, Fabry J. Randomized multi-centre trial of the effects of a catheter coated with hydrogel and silver salts on the incidence of hospital-acquired urinary tract infections. J Hosp Infect. 2000;45:117–124.
    1. Lai KK, Fontecchio SA. Use of silver-hydrogel urinary catheters on the incidence of catheter-associated urinary tract infections in hospitalized patients. Am J Infect Control. 2002;30:221–225.
    1. Gaonkar TA, Sampath LA, Modak SM. Evaluation of the antimicrobial efficacy of urinary catheters impregnated with antiseptics in an in vitro urinary tract model. Infect Control Hosp Epidemiol. 2003;24:506–513.
    1. Darouiche RO, Raad II, Smith JA. Efficacy of antimicrobial-impregnated bladder catheters in reducing catheter-associated bacteriuria: a prospective, randomized, multicenter clinical trial. Urology. 1999;54:976–981.
    1. Al-Habdan I, Sadat-Ali M, Corea JR, Al-Othman A, Kamal BA, Shriyan DS. Assessment of nosocomial urinary tract infections in orthopaedic patients: a prospective and comparative study using two different catheters. Int Surg. 2003;88:152–154.
    1. Riley DK, Classen DC, Stevens LE, Burke JP. A large randomized clinical trial of a silver-impregnated urinary catheter: lack of efficacy and staphylococcal superinfection. Am J Med. 1995;98:349–356.
    1. Johnson JR, Roberts PL, Olsen RJ, Moyer KA, Stamm WE. Prevention of catheter-associated urinary tract infection with a silver oxide-coated urinary catheter: clinical and microbiologic correlates. J Infect Dis. 1990;162:1145–1150.
    1. Liedberg H, Lundeberg T, Ekman P. Refinements in the coating of urethral catheters reduces the incidence of catheter-associated bacteriuria. An experimental and clinical study. Eur Urol. 1990;17:236–240.
    1. Liedberg H, Lundeberg T. Silver alloy coated catheters reduce catheter-associated bacteriuria. Br J Urol. 1990;65:379–381.
    1. Pickard R, Buckley B, Glazener C. Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short-term catheterisation in hospital: a multicentre randomised controlled trial. Lancet. 2012;380:1927–1935.
    1. Ward V, Wilson J, Taylor L, Cookson B, Glynn A. Preventing hospital-acquired infection: clinical guidelines. Public Health Laboratory Service; London: 1997.
    1. Stamm W. Urinary tract infections. In: Bennett JBP, editor. Hospital infection. 4th ed. Lippincott-Raven; Philadelphia: 1998. pp. 477–485.
    1. Kass EH, Schneiderman LJ. Entry of bacteria into the urinary tracts of patients with inlying catheters. N Engl J Med. 1957;256:556–557.
    1. Desautels RE, Walter CW, Graves RC, Harrison JH. Technical advances in the prevention of urinary tract infection. J Urol. 1962;87:487–490.
    1. Kunin CM, McCormack RC. Prevention of catheter-induced urinary-tract infections by sterile closed drainage. N Engl J Med. 1966;274:1155–1161.
    1. Garibaldi RA, Burke JP, Dickman ML, Smith CB. Factors predisposing to bacteriuria during indwelling urethral catheterization. N Engl J Med. 1974;291:215–219.
    1. Thornton GF, Andriole VT. Bacteriuria during indwelling catheter drainage: II. Effect of a closed sterile draining system. JAMA. 1970;214:339–342.
    1. Gillespie WA, Simpson RA, Jones JE, Nashef L, Teasdale C, Speller DC. Does the addition of disinfectant to urine drainage bags prevent infection in catheterised patients? Lancet. 1983;1:1037–1039.
    1. Gillespie WA, Lennon GG, Linton KB, Slade N. Prevention of urinary tract infection in gynaecology. BMJ. 1964;2:423–425.
    1. Platt R, Polk BF, Murdock B, Rosner B. Reduction of mortality associated with nosocomial urinary tract infection. Lancet. 1983;1:893–897.
    1. Keerasuntonpong A, Thamlikitkul V, Thearawiboon W. Incidence of urinary tract infections in patients with short-term indwelling urethral catheters: a comparison between a 3-day urinary drainage bag change and no change regimens. Am J Infect Control. 2003;31:9–12.
    1. Maizels M, Schaeffer AJ. Decreased incidence of bacteriuria associated with periodic instillations of hydrogen peroxide into the urethral catheter drainage bag. J Urol. 1980;123:841–845.
    1. Sweet DE, Goodpasture HC, Holl K, Smart S, Alexander H, Hedari A. Evaluation of H2O2 prophylaxis of bacteriuria in patients with long-term indwelling Foley catheters: a randomized controlled study. Infect Control. 1985;6:263–266.
    1. Thompson RL, Haley CE, Searcy MA. Catheter-associated bacteriuria. Failure to reduce attack rates using periodic instillations of a disinfectant into urinary drainage systems. JAMA. 1984;251:747–751.
    1. Cleland V, Cox F, Berggren H, Macinnis MR. Prevention of bacteriuria in female patients with indwelling catheters. Nurs Res. 1971;20:309–318.
    1. Burke JP, Garibaldi RA, Britt MR, Jacobson JA, Conti M, Alling DW. Prevention of catheter-associated urinary tract infections. Efficacy of daily meatal care regimens. Am J Med. 1981;70:655–658.
    1. Burke JP, Jacobson JA, Garibaldi RA, Conti MT, Alling DW. Evaluation of daily meatal care with poly-antibiotic ointment in prevention of urinary catheter-associated bacteriuria. J Urol. 1983;129:331–334.
    1. Classen DC, Larsen RA, Burke JP, Stevens LE. Prevention of catheter-associated bacteriuria: clinical trial of methods to block three known pathways of infection. Am J Infect Control. 1991;19:136–142.
    1. Classen DC, Larsen RA, Burke JP, Alling DW, Stevens LE. Daily meatal care for prevention of catheter-associated bacteriuria: results using frequent applications of polyantibiotic cream. Infect Control Hosp Epidemiol. 1991;12:157–162.
    1. Huth TS, Burke JP, Larsen RA, Classen DC, Stevens LE. Randomized trial of meatal care with silver sulfadiazine cream for the prevention of catheter-associated bacteriuria. J Infect Dis. 1992;165:14–18.
    1. Webster J, Hood RH, Burridge CA, Doidge ML, Phillips KM, George N. Water or antiseptic for periurethral cleaning before urinary catheterization: a randomized controlled trial. Am J Infect Control. 2001;29:389–394.
    1. Davies AJ, Desai HN, Turton S, Dyas A. Does instillation of chlorhexidine into the bladder of catheterized geriatric patients help reduce bacteriuria? J Hosp Infect. 1987;9:72–75.
    1. Ball AJ, Carr TW, Gillespie WA, Kelly M, Simpson RA, Smith PJ. Bladder irrigation with chlorhexidine for the prevention of urinary infection after transurethral operations: a prospective controlled study. J Urol. 1987;138:491–494.
    1. Jones MA, Hasan A. Controlled trial of intravesical noxythiolin in the prevention of infection following outflow tract surgery. Br J Urol. 1988;62:311–314.
    1. Schneeberger PM, Vreede RW, Bogdanowicz JF, van Dijk WC. A randomized study on the effect of bladder irrigation with povidone-iodine before removal of an indwelling catheter. J Hosp Infect. 1992;21:223–229.
    1. Warren JW, Platt R, Thomas RJ, Rosner B, Kass EH. Antibiotic irrigation and catheter-associated urinary-tract infections. N Engl J Med. 1978;299:570–573.
    1. Muncie HL, Jr, Hoopes JM, Damron DJ, Tenney JH, Warren JW. Once-daily irrigation of long-term urethral catheters with normal saline. Lack of benefit. Arch Intern Med. 1989;149:441–443.
    1. Kennedy AP, Brocklehurst JC, Robinson JM, Faragher EB. Assessment of the use of bladder washouts/instillations in patients with long-term indwelling catheters. Br J Urol. 1992;70:610–615.
    1. Cox F, Smith RF, Elliott JP, Quinn EL. Neomycin-polymyxin prophylaxis of urinary-tract infection associated with indwelling catheters. Antimicrob Agents Chemother. 1966;6:165–168.
    1. Getliffe KA. The use of bladder wash-outs to reduce urinary catheter encrustation. Br J Urol. 1994;73:696–700.
    1. Ranji SR, Shetty K, Posley KA. Closing the quality gap: a critical analysis of quality improvement strategies (Vol. 6: Prevention of healthcare-associated infections) Agency for Heathcare Research and Quality (US); Rockville (MD): 2007. Jan. Report No.: 04(07)-0051–6.
    1. Ching TY, Seto WH. Evaluating the efficacy of the infection control liaison nurse in the hospital. J Adv Nurs. 1990;15:1128–1131.
    1. O'Grady NP, Pearson ML, Raad II. Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis. 2011;52:e162–e193.
    1. Pittet D, Tarara D, Wenzel RP. Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. JAMA. 1994;271:1598–1601.
    1. Bregenzer TC, Sakmann D, Widmer P, Andreas F. Is routine replacement of peripheral intravenous catheters necessary? Arch Intern Med. 1998;158:151–156.
    1. Cornely OA, Bethe U, Pauls R, Waldschmidt D. Peripheral Teflon catheters: factors determining incidence of phlebitis and duration of cannulation. Infect Control Hosp Epidemiol. 2002;23:249–253.
    1. Grune F, Schrappe M, Basten J, Wenchel H, Tual E, Stutzer H. Phlebitis rate and time kinetics of short peripheral IV catheters. Infection. 2004;32:30–32.
    1. Rickard CM, Zhang L, McClymont A. Routine versus clinically indicated replacement of peripheral intravenous catheters: a randomised controlled equivalence trial. Lancet. 2012;380:1066–1074.
    1. Maki DG, Kluger DM, Crnich CJ. The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies. Mayo Clin Proc. 2006;81:1159–1171.
    1. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis. 2004;39:309–317.
    1. Gaynes R, Edwards JR, National Nosocomial Infections Surveillance System Overview of nosocomial infections caused by Gram-negative bacilli. Clin Infect Dis. 2005;41:848–854.
    1. Safdar N, Maki DG. The pathogenesis of catheter-related bloodstream infection with noncuffed short-term central venous catheters. Intensive Care Med. 2004;30:62–67.
    1. Maki DG, Weise CE, Sarafin HW. A semiquantitative culture method for identifying intravenous-catheter-related infection. N Engl J Med. 1977;296:1305–1309.
    1. Mermel LA, McCormick RD, Springman SR, Maki DG. The pathogenesis and epidemiology of catheter-related infection with pulmonary artery Swan-Ganz catheters: a prospective study utilizing molecular subtyping. Am J Med. 1991;91:197S–205S.
    1. Raad I, Costerton W, Sabharwal U, Sacilowski M, Anaissie E, Bodey GP. Ultrastructural analysis of indwelling vascular catheters: a quantitative relationship between luminal colonization and duration of placement. J Infect Dis. 1993;168:400–407.
    1. Dobbins BM, Kite P, Kindon A, McMahon MJ, Wilcox MH. DNA fingerprinting analysis of coagulase negative staphylococci implicated in catheter related bloodstream infections. J Clin Pathol. 2002;55:824–828.
    1. Anaissie E, Samonis G, Kontoyiannis D. Role of catheter colonization and infrequent hematogenous seeding in catheter-related infections. Eur J Clin Microbiol Infect Dis. 1995;14:134–137.
    1. Raad I, Mansour G, Hanna HA, Awad A, Alrahwan A, Bivins C. Optimal frequency of changing intravenous administration sets: is it safe to prolong use beyond 72 hours? Infect Control Hosp Epidemiol. 2001;22:136–139.
    1. Yoo S, Ha M, Choi D, Pai H. Effectiveness of surveillance of central catheter-related bloodstream infection in an ICU in Korea. Infect Control Hosp Epidemiol. 2001;22:433–436.
    1. Coopersmith CM, Rebmann TL, Zack JE. Effect of an education program on decreasing catheter-related bloodstream infections in the surgical intensive care unit. Crit Care Med. 2002;30:59–64.
    1. Sherertz RJ, Cruz J, Bowton DL. Education of physicians-in-training can decrease the risk for vascular catheter infection. Ann Intern Med. 2000;132:641–648.
    1. Eggimann P, Harbarth S, Constantin M, Touveneau S, Chevrolet J, Pittet D. Impact of a prevention strategy targeted at vascular-access care on incidence of infections acquired in intensive care. Lancet. 2000;355:1864–1868.
    1. Sanders RA, Sheldon GF. Septic complications of total parenteral nutrition. A five year experience. Am J Surg. 1976;132:214–220.
    1. Ryan JA, Jr, Abel RM, Abbott WM. Catheter complications in total parenteral nutrition. A prospective study of 200 consecutive patients. N Engl J Med. 1974;290:757–761.
    1. Murphy LM, Lipman TO. Central venous catheter care in parenteral nutrition: a review. J Parenter Enteral Nutr. 1987;11:190–201.
    1. Armstrong CW, Mayhall CG, Miller KB. Prospective study of catheter replacement and other risk factors for infection of hyperalimentation catheters. J Infect Dis. 1986;154:808–816.
    1. Frampton GK, Harris P, Cooper K, et al. Educational interventions for preventing vascular catheter bloodstream infections in critical care: evidence map, systematic review and economic evaluation. Health Technology Assessment. Project No. 09/01/25. Health Technol Assess in press.
    1. Snydman DR, Murray SA, Kornfeld SJ, Majka JA, Ellis CA. Total parenteral nutrition-related infections: prospective epidemiologic study using semiquantitative methods. Am J Med. 1982;73:695–699.
    1. Sheth NK, Franson TR, Rose HD, Buckmire FL, Cooper JA, Sohnle PG. Colonization of bacteria on polyvinyl chloride and Teflon intravascular catheters in hospitalized patients. J Clin Microbiol. 1983;18:1061–1063.
    1. Maki DG, Ringer M. Evaluation of dressing regimens for prevention of infection with peripheral intravenous catheters. Gauze, a transparent polyurethane dressing, and an iodophor-transparent dressing. JAMA. 1987;258:2396–2403.
    1. Pemberton LB, Lyman B, Lander V, Covinsky J. Sepsis from triple-vs single-lumen catheters during total parenteral nutrition in surgical or critically ill patients. Arch Surg. 1986;121:591–594.
    1. McCarthy MC, Shives JK, Robison RJ, Broadie TA. Prospective evaluation of single and triple lumen catheters in total parenteral nutrition. J Parenter Enteral Nutr. 1987;11:259–262.
    1. Hilton E, Haslett TM, Borenstein MT, Tucci V, Isenberg HD, Singer C. Central catheter infections: single-versus triple-lumen catheters. Influence of guide wires on infection rates when used for replacement of catheters. Am J Med. 1988;84:667–672.
    1. Yeung C, May J, Hughes R. Infection rate for single lumen v triple lumen subclavian catheters. Infect Control Hosp Epidemiol. 1988;9:154–158.
    1. Clark-Christoff N, Watters VA, Sparks W, Snyder P, Grant JP. Use of triple-lumen subclavian catheters for administration of total parenteral nutrition. J Parenter Enteral Nutr. 1992;16:403–407.
    1. Early TF, Gregory RT, Wheeler JR, Snyder SO, Jr, Gayle RG. Increased infection rate in double-lumen versus single-lumen Hickman catheters in cancer patients. South Med J. 1990;83:34–36.
    1. Farkas JC, Liu N, Bleriot JP, Chevret S, Goldstein FW, Carlet J. Single- versus triple-lumen central catheter-related sepsis: a prospective randomized study in a critically ill population. Am J Med. 1992;93:277–282.
    1. Gil RT, Kruse JA, Thill-Baharozian MC, Carlson RW. Triple- vs single-lumen central venous catheters. A prospective study in a critically ill population. Arch Intern Med. 1989;149:1139–1143.
    1. Dezfulian C, Lavelle J, Nallamothu BK, Kaufman SR, Saint S. Rates of infection for single-lumen versus multilumen central venous catheters: a meta-analysis. Crit Care Med. 2003;31:2385–2390.
    1. Zürcher M, Tramèr MR, Walder B. Colonization and bloodstream infection with single- versus multi-lumen central venous catheters: a quantitative systematic review. Anesth Analg. 2004;99:177–182.
    1. Pearson ML. Guideline for prevention of intravascular device-related infections. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol. 1996;17:438–473.
    1. Abrahm JL, Mullen JL. A prospective study of prolonged central venous access in leukemia. JAMA. 1982;248:2868–2873.
    1. Shapiro ED, Wald ER, Nelson KA, Spiegelman KN. Broviac catheter-related bacteremia in oncology patients. Am J Dis Child. 1982;136:679–681.
    1. Press OW, Ramsey PG, Larson EB, Fefer A, Hickman RO. Hickman catheter infections in patients with malignancies. Medicine. 1984;63:189–200.
    1. Darbyshire PJ, Weightman NC, Speller DC. Problems associated with indwelling central venous catheters. Arch Dis Child. 1985;60:129–134.
    1. Pessa ME, Howard RJ. Complications of Hickman-Broviac catheters. Surg Gynecol Obstet. 1985;161:257–260.
    1. Schuman ES, Winters V, Gross GF, Hayes JF. Management of Hickman catheter sepsis. Am J Surg. 1985;149:627–628.
    1. Rannem T, Ladefoged K, Tvede M, Lorentzen J, Jarnum S. Catheter-related septicemia in patients receiving home parenteral nutrition. Scand J Gastroenterol. 1986;21:455–460.
    1. Shulman RJ, Smith EO, Rahman S, Gardner P, Reed T, Mahoney D. Single- vs double-lumen central venous catheters in pediatric oncology patients. Am J Dis Child. 1988;142:893–895.
    1. Weightman NC, Simpson EM, Speller DC, Mott MG, Oakhill A. Bacteraemia related to indwelling central venous catheters: prevention, diagnosis and treatment. Eur J Clin Microbiol Infect Dis. 1988;7:125–129.
    1. Raad I, Davis S, Becker M. Low infection rate and long durability of nontunneled silastic catheters. A safe and cost-effective alternative for long-term venous access. Arch Intern Med. 1993;153:1791–1796.
    1. Andrivet P, Bacquer A, Ngoc CV. Lack of clinical benefit from subcutaneous tunnel insertion of central venous catheters in immunocompromised patients. Clin Infect Dis. 1994;18:199–206.
    1. Gyves JW, Ensminger WD, Niederhuber JE. A totally implanted injection port system for blood sampling and chemotherapy administration. JAMA. 1984;251:2538–2541.
    1. Lokich JJ, Bothe A, Jr, Benotti P, Moore C. Complications and management of implanted venous access catheters. J Clin Oncol. 1985;3:710–717.
    1. Khoury MD, Lloyd LR, Burrows J, Berg R, Yap J. A totally implanted venous access system for the delivery of chemotherapy. Cancer. 1985;56:1231–1234.
    1. McDowell HP, Hart CA, Martin J. Implantable subcutaneous venous catheters. Arch Dis Child. 1986;61:1037–1038.
    1. Brincker H, Saeter G. Fifty-five patient years' experience with a totally implanted system for intravenous chemotherapy. Cancer. 1986;57:1124–1129.
    1. Wurzel CL, Halom K, Feldman JG, Rubin LG. Infection rates of Broviac-Hickman catheters and implantable venous devices. Am J Dis Child. 1988;142:536–540.
    1. Kappers-Klunne MC, Degener JE, Stijnen T, Abels J. Complications from long-term indwelling central venous catheters in hematologic patients with special reference to infection. Cancer. 1989;64:1747–1752.
    1. Carde P, Cosset-Delaigue MF, Laplanche A, Chareau I. Classical external indwelling central venous catheter versus totally implanted venous access systems for chemotherapy administration: a randomized trial in 100 patients with solid tumors. Eur J Cancer Clin Oncol. 1989;25:939–944.
    1. Pegues D, Axelrod P, McClarren C. Comparison of infections in Hickman and implanted port catheters in adult solid tumor patients. J Surg Oncol. 1992;49:156–162.
    1. van der Pijl H, Frissen PH. Experience with a totally implantable venous access device (Port-A-Cath) in patients with AIDS. AIDS. 1992;6:709–713.
    1. Groeger JS, Lucas AB, Thaler HT. Infectious morbidity associated with long-term use of venous access devices in patients with cancer. Ann Intern Med. 1993;119:1168–1174.
    1. Galloway S, Bodenham A. Long-term central venous access. Br J Anaesth. 2004;92:722–734.
    1. Timsit JF, Sebille V, Farkas JC. Effect of subcutaneous tunneling on internal jugular catheter-related sepsis in critically ill patients: a prospective randomized multicenter study. JAMA. 1996;276:1416–1420.
    1. Timsit JF, Carlet J, Bruneel F. Use of tunneled femoral catheters to prevent catheter-related infection. A randomized, controlled trial. Ann Intern Med. 1999;130:729–735.
    1. Randolph AG, Cook DJ, Gonzales CA, Brun-Buisson C. Tunneling short-term central venous catheters to prevent catheter-related infection: a meta-analysis of randomized, controlled trials. Crit Care Med. 1998;26:1452–1457.
    1. Ryder MA. Peripheral access options. Surg Oncol Clin N Am. 1995;4:395–427.
    1. Bottino J, McCredie KB, Groschel DH, Lawson M. Long-term intravenous therapy with peripherally inserted silicone elastomer central venous catheters in patients with malignant diseases. Cancer. 1979;43:1937–1943.
    1. Graham DR, Keldermans MM, Klemm LW, Semenza NJ, Shafer ML. Infectious complications among patients receiving home intravenous therapy with peripheral, central, or peripherally placed central venous catheters. Am J Med. 1991;91(Suppl. 2):S95–S100.
    1. Merrell SW, Peatross BG, Grossman MD, Sullivan JJ, Harker WG. Peripherally inserted central venous catheters. Low-risk alternatives for ongoing venous access. West J Med. 1994;160:25–30.
    1. Thiagarajan RR, Ramamoorthy C, Gettmann T, Bratton SL. Survey of the use of peripherally inserted central venous catheters in children. Pediatrics. 1997;99:e4.
    1. Skiest DJ, Abbott M, Keiser P. Peripherally inserted central catheters in patients with AIDS are associated with a low infection rate. Clin Infect Dis. 2000;30:949–952.
    1. Safdar N, Maki DG. Risk of catheter-related bloodstream infection with peripherally inserted central venous catheters used in hospitalized patients. Chest. 2005;128:489–495.
    1. Maki DG, Stolz SM, Wheeler S, Mermel LA. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter. A randomized, controlled trial. Ann Intern Med. 1997;127:257–266.
    1. Logghe C, Van Ossel C, D'Hoore W, Ezzedine H, Wauters G, Haxhe JJ. Evaluation of chlorhexidine and silver-sulfadiazine impregnated central venous catheters for the prevention of bloodstream infection in leukaemic patients: a randomized controlled trial. J Hosp Infect. 1997;37:145–156.
    1. Heard SO, Wagle M, Vijayakumar E, McLean S, Brueggemann A, Napolitano LM. Influence of triple-lumen central venous catheters coated with chlorhexidine and silver sulfadiazine on the incidence of catheter-related bacteremia. Arch Intern Med. 1998;158:81–87.
    1. Haxhe JJ, D'Hoore W. A meta-analysis dealing with the effectiveness of chlorhexidine and silver-sufhadiazine impregnated central venous catheters. J Hosp Infect. 1998;40:166–168.
    1. Oda T, Hamasaki J, Kanda N, Mikami K. Anaphylactic shock induced by an antiseptic-coated central venous [correction of nervous] catheter. Anesthesiology. 1997;87:1242–1244.
    1. Veenstra DL, Saint S, Sullivan SD. Cost-effectiveness of antiseptic-impregnated central venous catheters for the prevention of catheter-related bloodstream infection. JAMA. 1999;282:554–560.
    1. Raad I, Buzaid A, Robertson C. Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections. A randomized, double-blind trial. The Texas Medical Center Catheter Study Group. Ann Intern Med. 1997;127:267–274.
    1. Collin GR. Decreasing catheter colonization through the use of an antiseptic-impregnated catheter: a continuous quality improvement project. Chest. 1999;115:1632–1640.
    1. Darouiche RO, Hachem R, Harris RL, Mayhall G, Raad II, Heard SO. A Comparison of Two Antimicrobial-Impregnated Central Venous Catheters. N Engl J Med. 1999;340:1–8.
    1. Veenstra DL, Saint S, Saha S, Lumley T, Sullivan SD. Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-analysis. JAMA. 1999;281:261–267.
    1. Mermel LA. Prevention of intravascular catheter-related infections. Ann Intern Med. 2000;132:391–402.
    1. Walder B, Pittet D, Tramèr MR. Prevention of bloodstream infections with central venous catheters treated with anti-infective agents depends on catheter type and insertion time: evidence from a meta-analysis. Infect Control Hosp Epidemiol. 2002;23:748–756.
    1. Bassetti S, Hu J, D'Agostino RB, Jr, Sherertz RJ. Prolonged Antimicrobial Activity of a Catheter Containing Chlorhexidine-Silver Sulfadiazine Extends Protection against Catheter Infections In Vivo. Antimicrob Agents Chemother. 2001;45:1535–1538.
    1. Hockenhull J, Dwan K, Boland A, Smith G, Bagust A, Dickson R. The clinical effectiveness and cost-effectiveness of central venous catheters treated with anti-infective agents in preventing bloodstream infections: a systematic review and economic evaluation. Health Technol Assess. 2008;12:1–154.
    1. Lai NM, Chaiyakunapruk N, Lai NA, O'Riordan E, Pau WS, Saint S. Catheter impregnation, coating or bonding for reducing central venous catheter-related infections in adults. Cochrane Database Syst Rev. 2013;(6)
    1. Wang H, Huang T, Jing J, Jin J, Wang P, Yang M. Effectiveness of different central venous catheters for catheter-related infections: a network meta-analysis. J Hosp Infect. 2010;76:1–11.
    1. Walz JM, Avelar RL, Longtine KJ, Carter KL, Mermel LA, Heard SO. Anti-infective external coating of central venous catheters: a randomized, noninferiority trial comparing 5-fluorouracil with chlorhexidine/silver sulfadiazine in preventing catheter colonization. Crit Care Med. 2010;38:2095–2102.
    1. Nakonechna A, Dorea P, Dixon T. Immediate hypersensitivity to chlorhexidine is increasingly recognised in the United Kingdom. Allergol Immunopathol. 2012; Dec19 pii: S0301-0546(12)00262-5. [Epub ahead of print]
    1. Guleri A, Kumar A, Morgan RJ, Hartley M, Roberts DH. Anaphylaxis to chlorhexidine-coated central venous catheters: a case series and review of the literature. Surg Infect. 2012;13:171–174.
    1. Medicines and Healthcare Products Regulatory Agency . Medical Device Alert: All medical devices and medicinal products containing chlorhexidine. Medicines and Healthcare Products Regulatory Agency; London: 2012. MDA/2012/075.
    1. Parienti JJ, Thirion M, Megarbane B. Femoral vs jugular venous catheterization and risk of nosocomial events in adults requiring acute renal replacement therapy: a randomized controlled trial. JAMA. 2008;299:2413–2422.
    1. Moretti EW, Ofstead CL, Kristy RM, Wetzler HP. Impact of central venous catheter type and methods on catheter-related colonization and bacteraemia. J Hosp Infect. 2005;61:139–145.
    1. Nagashima G, Kikuchi T, Tsuyuzaki H. To reduce catheter-related bloodstream infections: is the subclavian route better than the jugular route for central venous catheterization? J Infect Chemother. 2006;12:363–365.
    1. Ruesch S, Walder B, Tramer MR. Complications of central venous catheters: internal jugular versus subclavian access – a systematic review. Crit Care Med. 2002;30:454–460.
    1. Sadoyama G, Gontijo Filho PP. Comparison between the jugular and subclavian vein as insertion site for central venous catheters: microbiological aspects and risk factors for colonization and infection. Braz J Infect Dis. 2003;7:142–148.
    1. Richet H, Bouvier AM, Hubert B. Prospective multicenter study of vascular-catheter-related complications and risk factors for positive central-catheter cultures in intensive care unit patients. J Clin Microbiol. 1990;28:2520–2525.
    1. Safdar N, Kluger DM, Maki DG. A review of risk factors for catheter-related bloodstream infection caused by percutaneously inserted, noncuffed central venous catheters: implications for preventive strategies. Medicine. 2002;81:466–479.
    1. Lorente L, Jimenez A, Iribarren JL, Jimenez JJ, Martin MM, Mora ML. The micro-organism responsible for central venous catheter related bloodstream infection depends on catheter site. Intensive Care Med. 2006;32:1449–1450.
    1. Traore O, Liotier J, Souweine B. Prospective study of arterial and central venous catheter colonization and of arterial- and central venous catheter-related bacteremia in intensive care units. Crit Care Med. 2005;33:1276–1280.
    1. Merrer J, De Jonghe B, Golliot F. Complications of femoral and subclavian venous catheterization in critically ill patients: a randomized controlled trial. JAMA. 2001;286:700–707.
    1. Goetz AM, Wagener MM, Miller JM, Muder RR. Risk of infection due to central venous catheters: effect of site of placement and catheter type. Infect Control Hosp Epidemiol. 1998;19:842–845.
    1. Deshpande KS, Hatem C, Ulrich HL. The incidence of infectious complications of central venous catheters at the subclavian, internal jugular, and femoral sites in an intensive care unit population. Crit Care Med. 2005;33:13–20.
    1. Marik PE, Flemmer M, Harrison W. The risk of catheter-related bloodstream infection with femoral venous catheters as compared to subclavian and internal jugular venous catheters: a systematic review of the literature and meta-analysis. Crit Care Med. 2012;40:2479–2485.
    1. Randolph AG, Cook DJ, Gonzales CA, Pribble CG. Ultrasound guidance for placement of central venous catheters: a meta-analysis of the literature. Crit Care Med. 1996;24:2053–2058.
    1. Hind D, Calvert N, McWilliams R. Ultrasonic locating devices for central venous cannulation: meta-analysis. BMJ. 2003;327:361–364.
    1. National Institute for Health and Care Excellence . Guidance on the use of ultrasound locating devices for placing central venous catheters (No.49) National Insititute for Clinical Excellence; London: 2002. Accessed July 25, 2013.
    1. Maki DG, Goldman DA, Rhame FS. Infection control in intravenous therapy. Ann Intern Med. 1973;79:867–887.
    1. Raad II, Hohn DC, Gilbreath BJ. Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion. Infect Control Hosp Epidemiol. 1994;15:231–238.
    1. Carrer S, Bocchi A, Bortolotti M. Effect of different sterile barrier precautions and central venous catheter dressing on the skin colonization around the insertion site. Minerva Anestesiol. 2005;71:197–206.
    1. Hu KK, Lipsky BA, Veenstra DL, Saint S. Using maximal sterile barriers to prevent central venous catheter-related infection: a systematic evidence-based review. Am J Infect Control. 2004;32:142–146.
    1. Fletcher S, Bodenham A. Catheter-related sepsis: an overview -Part 1. Br J Int Care. 1999;9:46–53.
    1. Maki DG, Ringer M, Alvarado CJ. Prospective randomised trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet. 1991;338:339–343.
    1. Mimoz O, Pieroni L, Lawrence C. Prospective, randomized trial of two antiseptic solutions for prevention of central venous or arterial catheter colonization and infection in intensive care unit patients. Crit Care Med. 1996;24:1818–1823.
    1. Parienti JJ, du Cheyron D, Ramakers M. Alcoholic povidone-iodine to prevent central venous catheter colonization: a randomized unit-crossover study. Crit Care Med. 2004;32:708–713.
    1. Chaiyakunapruk N, Veenstra DL, Lipsky BA, Saint S. Chlorhexidine compared with povidone-iodine solution for vascular catheter-site care: a meta-analysis. Ann Intern Med. 2002;136:792–801.
    1. Chaiyakunapruk N, Veenstra DL, Lipsky BA, Sullivan SD, Saint S. Vascular catheter site care: the clinical and economic benefits of chlorhexidine gluconate compared with povidone iodine. Clin Infect Dis. 2003;37:764–771.
    1. Larson E. Guideline for use of topical antimicrobial agents. Am J Infect Control. 1988;16:253–266.
    1. Rannem T, Ladefoged K, Hegnhoj J, Moller EH, Bruun B, Jarnum S. Catheter-related sepsis in long-term parenteral nutrition with Broviac catheters. An evaluation of different disinfectants. Clin Nutr. 1990;9:131–136.
    1. Prager RL, Silva J., Jr Colonization of central venous catheters. South Med J. 1984;77:458–461.
    1. Moran JM, Atwood RP, Rowe MI. A clinical and bacteriologic study of infections associated with venous cutdowns. N Engl J Med. 1965;272:554–560.
    1. Norden CW. Application of antibiotic ointment to the site of venous catheterization – a controlled trial. J Infect Dis. 1969;120:611–615.
    1. Zinner SH, Denny-Brown BC, Braun P, Burke JP, Toala P, Kass EH. Risk of infection with intravenous indwelling catheters: effect of application of antibiotic ointment. J Infect Dis. 1969;120:616–619.
    1. Jarrard MM, Freeman JB. The effects of antibiotic ointments and antiseptics on the skin flora beneath subclavian catheter dressings during intravenous hyperalimentation. J Surg Res. 1977;22:520–526.
    1. Maki DG, Band JD. A comparative study of polyantibiotic and iodophor ointments in prevention of vascular catheter-related infection. Am J Med. 1981;70:739–744.
    1. Maiwald M, Chan ESY. The forgotten role of alcohol: a systematic review and meta-analysis of the clinical efficacy and perceived role of chlorhexidine in skin antisepsis. PLoS One. 2012;7:e44277.
    1. Hoffmann KK, Weber DJ, Samsa GP, Rutala WA. Transparent polyurethane film as an intravenous catheter dressing. A meta-analysis of the infection risks. JAMA. 1992;267:2072–2076.
    1. Gillies D, O'Riordan L, Carr D, Frost J, Gunning R, O'Brien I. Gauze and tape and transparent polyurethane dressings for central venous catheters. Cochrane Database Syst Rev. 2003;4 CD003827.
    1. Webster J, Gillies D, O'Riordan E, Sherriff KL, Rickard CM. Gauze and tape and transparent polyurethane dressings for central venous catheters. Cochrane Database Syst Rev. 2011;9 CD003827.
    1. Chan R, Northfield S, Alexander A, Rickard C. Using the collaborative evidence based practice model: a systematic review and uptake of chlorhexidine-impregnated sponge dressings on central venous access devices in a tertiary cancer centre. Aust J Cancer Nurs. 2012;13:10–15.
    1. Schwebel C, Lucet JC, Vesin A. Economic evaluation of chlorhexidine-impregnated sponges for preventing catheter-related infections in critically ill adults in the Dressing Study. Crit Care Med. 2012;40:11–17.
    1. Timsit JF, Mimoz O, Mourvillier B. Randomized controlled trial of chlorhexidine dressing and highly adhesive dressing for preventing catheter-related infections in critically ill adults. Am J Respir Crit Care Med. 2012;186:1272–1278.
    1. O'Horo JC, Silva GL, Munoz-Price LS, Safdar N. The efficacy of daily bathing with chlorhexidine for reducing healthcare-associated bloodstream infections: a meta-analysis. Infect Control Hosp Epidemiol. 2012;33:257–267.
    1. Dettenkofer M, Wilson C, Gratwohl A. Skin disinfection with octenidine dihydrochloride for central venous catheter site care: a double-blind, randomized, controlled trial. Clin Microbiol Infect. 2010;16:600–606.
    1. Eyer S, Brummitt C, Crossley K, Siegel R, Cerra F. Catheter-related sepsis: prospective, randomized study of three methods of long-term catheter maintenance. Crit Care Med. 1990;18:1073–1079.
    1. Uldall PR, Merchant N, Woods F, Yarworski U, Vas S. Changing subclavian haemodialysis cannulas to reduce infection. Lancet. 1981;317:1373.
    1. Cobb DK, High KP, Sawyer RG. A controlled trial of scheduled replacement of central venous and pulmonary-artery catheters. N Engl J Med. 1992;327:1062–1068.
    1. Cook D, Randolph A, Kernerman P. Central venous catheter replacement strategies: a systematic review of the literature. Crit Care Med. 1997;25:1417–1424.
    1. Rickard CM, McCann D, Munnings J, McGrail MR. Routine resite of peripheral intravenous devices every 3 days did not reduce complications compared with clinically indicated resite: a randomised controlled trial. BMC Med. 2010;8:53.
    1. Webster J, Osborne S, Rickard C, New K. Clinically-indicated replacement versus routine replacement of peripheral venous catheters. Cochrane Database Syst Rev. 2013;4 (CD007798).
    1. De Cicco M, Chiaradia V, Veronesi A. Source and route of microbial colonisation of parenteral nutrition catheters. Lancet. 1989;334:1258–1261.
    1. Capell S, Linares J, Sitges-Serra A. Catheter sepsis due to coagulase-negative staphylococci in patients on total parenteral nutrition. Eur J Clin Microbiol. 1986;5:40–42.
    1. Salzman MB, Isenberg HD, Shapiro JF, Lipsitz PJ, Rubin LG. A prospective study of the catheter hub as the portal of entry for microorganisms causing catheter-related sepsis in neonates. J Infect Dis. 1993;167:487–490.
    1. Peters G, Locci R, Pulverer G. Adherence and growth of coagulase-negative staphylococci on surfaces of intravenous catheters. J Infect Dis. 1982;146:479–482.
    1. Liñares J, Sitges-Serra A, Garau J, Pérez JL, Martín R. Pathogenesis of catheter sepsis: a prospective study with quantitative and semiquantitative cultures of catheter hub and segments. J Clin Microbiol. 1985;21:357–360.
    1. Sitges-Serra A, Linares J, Perez JL, Jaurrieta E, Lorente L. A randomized trial on the effect of tubing changes on hub contamination and catheter sepsis during parenteral nutrition. J Parenter Enteral Nutr. 1985;9:322–325.
    1. Weist K, Sperber A, Dietz E, Ruden H. Contamination of stopcocks mounted in administration sets for central venous catheters with replacement at 24 hrs versus 72 hrs: a prospective cohort study. Infect Control Hosp Epidemiol. 1997;18:24.
    1. Salzman MB, Isenberg HD, Rubin LG. Use of disinfectants to reduce microbial contamination of hubs of vascular catheters. J Clin Microbiol. 1993;31:475–479.
    1. Ruschman KL, Fulton JS. Effectiveness of disinfectant techniques on intravenous tubing latex injection ports. J Intraven Nurs. 1993;16:304–308.
    1. Casey AL, Worthington T, Lambert PA, Quinn D, Faroqui MH, Elliott TSJ. A randomized, prospective clinical trial to assess the potential infection risk associated with the PosiFlow ® needleless connector. J Hosp Infect. 2003;54:288–293.
    1. Simmons S, Bryson C, Porter S. ‘Scrub the hub’: cleaning duration and reduction in bacterial load on central venous catheters. Crit Care Nurs Q. 2011;34:31.
    1. Kaler W, Chinn R. Successful disinfection of needleless access ports: a matter of time and friction. JAVA. 2007;12:140–142.
    1. Snaterse M, Rüger W, Scholte op Reimer WJM, Lucas C. Antibiotic-based catheter lock solutions for prevention of catheter-related bloodstream infection: a systematic review of randomised controlled trials. J Hosp Infect. 2010;75:1–11.
    1. Slobbe L, Doorduijn JK, Lugtenburg PJ. Prevention of catheter-related bacteremia with a daily ethanol lock in patients with tunnelled catheters: a randomized, placebo-controlled trial. PLoS One. 2010;5:e10840.
    1. Centers for Disease Control and Prevention Guidelines for the prevention of intravascular-catheter-related infections. MMWR. 2002;51:1–29.
    1. Morris K, Howard P. Can high-level mupirocin resistance reporting be relied upon to ensure patients are prescribed appropriate treatment? ECCMID. 2012:2378.
    1. van de Wetering MD, van Woensel JB. Prophylactic antibiotics for preventing early central venous catheter Gram positive infections in oncology patients. Cochrane Database Syst Rev. 2003;2 CD003295.
    1. Hoar PF, Wilson RM, Mangano DT, Avery GJ, 2nd, Szarnicki RJ, Hill JD. Heparin bonding reduces thrombogenicity of pulmonary-artery catheters. N Engl J Med. 1981;305:993–995.
    1. Ge X, Cavallazzi R, Li C, Pan SM, Wang YW, Wang FL. Central venous access sites for the prevention of venous thrombosis, stenosis and infection. Cochrane Database Syst Rev. 2012;3 CD004084.
    1. Raad II, Luna M, Khalil SA, Costerton JW, Lam C, Bodey GP. The relationship between the thrombotic and infectious complications of central venous catheters. JAMA. 1994;271:1014–1016.
    1. Chastre J, Cornud F, Bouchama A, Viau F, Benacerraf R, Gibert C. Thrombosis as a complication of pulmonary-artery catheterization via the internal jugular vein: prospective evaluation by phlebography. N Engl J Med. 1982;306:278–281.
    1. Valerio D, Hussey J, Smith F. Central vein thrombosis associated with intravenous feeding – a prospective study. J Parenter Enteral Nutr. 1981;5:240–242.
    1. Andrew M, Marzinotto V, Pencharz P. A cross-sectional study of catheter-related thrombosis in children receiving total parenteral nutrition at home. J Pediatr. 1995;126:358–363.
    1. Krafte-Jacobs B, Sivit CJ, Mejia R, Pollack MM. Catheter-related thrombosis in critically ill children: comparison of catheters with and without heparin bonding. J Pediatr. 1995;126:50–54.
    1. Talbott G, Winters W, Bratton S, O'Rourke P. A prospective study of femoral catheter-related thrombosis in children. Arch Pediatr Adolesc Med. 1995;149:288–291.
    1. Randolph AG, Cook DJ, Gonzales CA, Andrew M. Benefit of heparin in central venous and pulmonary artery catheters: a meta-analysis of randomized controlled trials. Chest. 1998;113:165–171.
    1. Bern MM, Lokich JJ, Wallach SR. Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trial. Ann Intern Med. 1990;112:423–428.
    1. Abdelkefi A, Abdeladhim AB, Torjman L. Randomized trial of prevention of catheter-related bloodstream infection by continuous infusion of low-dose unfractionated heparin in patients with hematologic and oncologic disease. J Clin Oncol. 2005;23:7864–7870.
    1. Pierce CM, Wade A, Mok Q. Heparin-bonded central venous lines reduce thrombotic and infective complications in critically ill children. Intensive Care Med. 2000;26:967–972.
    1. Appelgren P, Ransjo U, Bindslev L, Espersen F, Larm O. Surface heparinization of central venous catheters reduces microbial colonization in vitro and in vivo: results from a prospective, randomized trial. Crit Care Med. 1996;24:1482–1489.
    1. Abdelkefi A, Achour W, Ben Othman T. Use of heparin-coated central venous lines to prevent catheter-related bloodstream infection. J Support Oncol. 2007;5:273–278.
    1. Shah PS, Shah N. Heparin-bonded catheters for prolonging the patency of central venous catheters in children. Cochrane Database Syst Rev. 2007;4 CD005983.
    1. Boraks P, Seale J, Price J. Prevention of central venous catheter associated thrombosis using minidose warfarin in patients with haematological malignancies. Br J Haematol. 1998;101:483–486.
    1. Akl E, Karmath G, Yosuico V. Anticoagulation for thrombosis prophylaxis in cancer patients with central venous catheters. Cochrane Database Syst Rev. 2007;18 CD00646.
    1. Akl EA, Muti P, Schunemann HJ. Anticoagulation in patients with cancer: an overview of reviews. Pol Arch Med Wewn. 2008;118:183–193.
    1. Klerk CP, Smorenburg SM, Buller HR. Thrombosis prophylaxis in patient populations with a central venous catheter: a systematic review. Arch Intern Med. 2003;163:1913–1921.
    1. Passannante A, Macik BG. The heparin flush syndrome: a cause of iatrogenic hemorrhage. Am J Med Sci. 1988;296:71–73.
    1. Randolph AG, Cook DJ, Gonzales CA, Andrew M. Benefit of heparin in peripheral venous and arterial catheters: systematic review and meta-analysis of randomised controlled trials. BMJ. 1998;316:969–975.
    1. Goode CJ, Titler M, Rakel B. A meta-analysis of effects of heparin flush and saline flush: quality and cost implications. Nurs Res. 1991;40:324–330.
    1. Peterson FY, Kirchhoff KT. Analysis of the research about heparinized versus nonheparinized intravascular lines. Heart Lung. 1991;20:631–640.
    1. Mitchell MD, Anderson BJ, Williams K, Umscheid CA. Heparin flushing and other interventions to maintain patency of central venous catheters: a systematic review. J Adv Nurs. 2009;65:2007–2021.
    1. Schallom ME, Prentice D, Sona C, Micek ST, Skrupky LP. Heparin or 0.9% sodium chloride to maintain central venous catheter patency: a randomized trial. Crit Care Med. 2012;40:1820–1826.
    1. Bertolino G, Pitassi A, Tinelli C. Intermittent flushing with heparin versus saline for maintenance of peripheral intravenous catheters in a medical department: a pragmatic cluster-randomized controlled study. Worldviews Evid Based Nurs. 2012;9:221–226.
    1. Rupp ME, Sholtz LA, Jourdan DR. Outbreak of bloodstream infection temporally associated with the use of an intravascular needleless valve. Clin Infect Dis. 2007;44:1408–1414.
    1. Salgado CD, Chinnes L, Paczesny TH, Cantey JR. Increased rate of catheter-related bloodstream infection associated with use of a needleless mechanical valve device at a long-term acute care hospital. Infect Control Hosp Epidemiol. 2007;28:684–688.
    1. Maragakis LL, Bradley KL, Song X. Increased catheter-related bloodstream infection rates after the introduction of a new mechanical valve intravenous access port. Infect Control Hosp Epidemiol. 2006;27:67–70.
    1. Field K, Athan E, McFarlane C. Incidence of catheter-related bloodstream infection among patients with a needleless, mechanical valve-based intravenous connector in an Australian hematology-oncology unit. Infect Control Hosp Epidemiol. 2007;28:610–613.
    1. Gillies D, O'Riordan L, Wallen M, Morrison A, Rankin K, Nagy S. Optimal timing for intravenous administration set replacement. Cochrane Database Syst Rev. 2005;4 CD003588.
    1. Department of Health . Saving lives: a delivery programme to reduce healthcare associated infection including MRSA. Department of Health; London: 2005.
    1. Berenholtz SM, Pronovost PJ, Lipsett PA. Eliminating catheter-related bloodstream infections in the intensive care unit. Crit Care Med. 2004;32:2014–2020.
    1. Pronovost P, Roth G, Bander J. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med. 2006;355:2725–2732.
    1. Pronovost PJ, Sexton JB, Marsteller JA. Sustaining reductions in catheter related bloodstream infections in Michigan intensive care units: observational study. BMJ. 2010;4:c309.
    1. Curran E, Harper P, Loveday H. Results of a multicentre randomised controlled trial of statistical process control charts and structured diagnostic tools to reduce ward-acquired meticillin-resistant Staphylococcus aureus: the CHART Project. J Hosp Infect. 2008;70:127–135.
    1. Scales DC, Dainty K, Hales B. A multifaceted intervention for quality improvement in a network of intensive care units: a cluster randomized trial. JAMA. 2011;305:363–372.
    1. Munoz-Price LS, Dezfulian C, Wyckoff M. Effectiveness of stepwise interventions targeted to decrease central catheter-associated bloodstream infections. Crit Care Med. 2012;40:1464–1469.
    1. Bion J, Bellingan G, Patten M. ‘Matching Michigan’: a 2-year stepped interventional programme to minimise central venous catheter-blood stream infections in intensive care units in England. BMJ. 2013;22:110–123.
    1. Halton KA, Cook D, Paterson DL, Safdar N, Graves N. Cost-effectiveness of a central venous catheter care bundle. PLoS One. 2010;5:e12815.
    1. Berwick D, Calkins D, McCannon C, Hackard A. The 100,000 lives campaign: setting a goal and deadline for improving healthcare quality. JAMA. 2006;295:326–327.

Source: PubMed

Sponsorit ja yhteistyökumppanit

Sairaudet

Huumeiden interventiot

3
Tilaa